Investigation of a mouse and a sheep model to study pathogenic mechanisms of Campylobacter jejuni fetoplacental infection by Lashley, Victoria Dale
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2016
Investigation of a mouse and a sheep model to
study pathogenic mechanisms of Campylobacter
jejuni fetoplacental infection
Victoria Dale Lashley
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Animal Diseases Commons, Pathology Commons, and the Veterinary Medicine
Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Lashley, Victoria Dale, "Investigation of a mouse and a sheep model to study pathogenic mechanisms of Campylobacter jejuni
fetoplacental infection" (2016). Graduate Theses and Dissertations. 15950.
https://lib.dr.iastate.edu/etd/15950
  
 
Investigation of a mouse and a sheep model to study pathogenic mechanisms 
of Campylobacter jejuni fetoplacental infection 
 
 
by 
 
 
Victoria Dale Lashley  
 
 
 
 
A dissertation submitted to the graduate faculty 
 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY  
 
 
Major: Veterinary Pathology 
 
Program of Study Committee: 
Michael Yaeger, Major Professor  
Qijing Zhang  
Paul Plummer 
Mark Ackermann  
Jesse Hostetter 
 
 
 
 
 
 
 
Iowa State University 
 
Ames, Iowa 
 
2016 
 
 
Copyright © Victoria Dale Lashley, 2016. All rights reserved.
ii 
 
 
This dissertation is dedicated to: 
 
My parents, Ruthven and Barbara 
My children, Ivana and Yadavendra 
 
iii 
 
 
TABLE OF CONTENTS 
 
              Page 
LIST OF FIGURES ................................................................................................... v 
LIST OF TABLES ..................................................................................................... vi 
CHAPTER 1 GENERAL INTRODUCTION ....................................................... 1 
 Statement of the Problem ..................................................................................... 1 
 Specific aims ........................................................................................................ 2 
 Dissertation Organization .................................................................................... 3 
 Literature Review................................................................................................. 4 
  C. jejuni: Epidemiology and significance ...................................................... 4 
  C. jejuni as a reproductive pathogen and cause of abortion .......................... 7 
  Animal models for the study of reproductive Campylobacter sp infection ... 10 
  C. jejuni, cytokines, apoptosis, TLR4 and NFκB .......................................... 12 
 References ......................................................................................................... 15 
 
CHAPTER 2  INVESTIGATING THE SUITABILITY OF A  
LABORATORY MOUSE MODEL TO STUDY THE PATHOGENESIS OF 
ABORTIFACIENT CAMPYLOBACTER JEJUNI .................................................... 23 
 Abstract  ......................................................................................................... 23 
 Introduction ......................................................................................................... 25  
 Materials and Methods ......................................................................................... 26 
 Results  ......................................................................................................... 33 
 Discussion ......................................................................................................... 38 
 Conclusion ......................................................................................................... 45 
 References ......................................................................................................... 47 
 Tables  ......................................................................................................... 50 
 Figures  ......................................................................................................... 52  
 
 
CHAPTER 3  THE USE OF A SERUM CYTOKINE ASSAY AND IN SITU 
HYBRIDIZATION TO EVALUATE PRO-INFLAMMATORY AND ANTI-
INFLAMMATORY CYTOKINES IN THE UTERUS AND PLACENTA OF 
CAMPYLOBACTER JEJUNI IA3902 INFECTED MICE ........................................ 54 
 Abstract  ......................................................................................................... 54 
 Introduction ......................................................................................................... 56  
 Materials and Methods ......................................................................................... 59 
 Results  ......................................................................................................... 64 
 Discussion ......................................................................................................... 66 
 Conclusion ......................................................................................................... 71 
iv 
 
 
 References ......................................................................................................... 73 
 Tables  ......................................................................................................... 78 
 Figures  ......................................................................................................... 79 
 
CHAPTER 4     EVALUATION OF THREE DIFFERENT INOCULATION  
ROUTES FOR THE INDUCTION OF SHEEP ABORTION BY  
CAMPYLOBACTER JEJUNI CLONE SA ................................................................ 80
 Abstract  ......................................................................................................... 80 
 Introduction ......................................................................................................... 82  
 Materials and Methods ......................................................................................... 84 
 Results  ......................................................................................................... 89 
 Discussion ......................................................................................................... 91 
 Conclusion ......................................................................................................... 97 
 References ......................................................................................................... 99 
 Tables  ......................................................................................................... 102 
 Figures  ......................................................................................................... 106 
 
 
CHAPTER 5  MUCIN, L-FUCOSE, IRON, TOLL-LIKE RECEPTOR 4  
AND CASPASE 3 IN THE OVINE PLACENTA INFECTED WITH  
C. JEJUNI CLONE SA.............................................................................................. 107 
 Abstract  ......................................................................................................... 107 
 Introduction ......................................................................................................... 108  
 Materials and Methods ......................................................................................... 110 
 Results  ......................................................................................................... 116 
 Discussion ......................................................................................................... 118 
 Acknowledgments................................................................................................ 123  
 References ......................................................................................................... 124 
 Tables  ......................................................................................................... 127 
 Figures  ......................................................................................................... 128 
 
 
CHAPTER 5  GENERAL CONCLUSIONS ......................................................... 130 
 Conclusions and Recommendations for future research ...................................... 130
 References  .......................................................................................................... 134 
 
 
ACKNOWLEDGEMENTS ....................................................................................... 135 
v 
 
 
LIST OF FIGURES  
 
 
                                                                                                                                       Page 
CHAPTER 2  INVESTIGATING THE SUITABILITY OF A  
LABORATORY MOUSE MODEL TO STUDY THE PATHOGENESIS OF 
ABORTIFACIENT CAMPYLOBACTER JEJUNI 
 Figure 1  Two mid-term dead fetuses and placentitis ....................................... 52 
 Figure 2  Two resorbed fetuses ......................................................................... 52 
 Figure 3  PAS stain ............................................................................................ 53 
 Figure 4  Perls’ iron stain .................................................................................. 53 
 Figure 5  Lectin histochemistry for LTA .......................................................... 53 
 Figure 6  Placental disc stained for the membrane outer protein 
   of C. jejuni (MOMP).......................................................................... 53 
 
 
CHAPTER 3     THE USE OF A SERUM CYTOKINE ASSAY AND  
IN SITU HYBRIDIZATION TO EVALUATE PRO-INFLAMMATORY  
AND ANTI-INFLAMMATORY CYTOKINES IN THE UTERUS  
AND PLACENTA OF CAMPYLOBACTER JEJUNI IA3902  
INFECTED MICE 
 Figure 1  Photomicrographs of RNAscope
®
 sections of 
 murine placental discs infected with C. jejuni IA3902, 
 probed and stained for cytokines and C. jejuni IA3902 ....................................... 79 
 
 
CHAPTER 4     EVALUATION OF THREE DIFFERENT INOCULATION  
ROUTES FOR THE INDUCTION OF SHEEP ABORTION BY  
CAMPYLOBACTER JEJUNI CLONE SA 
 Figure 1     Photomicrographs of ovine placenta, endometrial glands, 
      liver and gallbladder after inoculation with C. jejuni IA3902 ............................. 106 
 
 
CHAPTER 5  MUCIN, L-FUCOSE, TOLL-LIKE RECEPTOR 4  
AND CASPASE 3 IN THE OVINE PLACENTA INFECTED  
WITH C. JEJUNI CLONE SA 
 Figures 1-8     Photomicrographs of ovine placenta and  
 endometrial glands after infection with C. jejuni IA3902. .................................. 128 
   
 
  
 
vi 
 
 
LIST OF TABLES  
 
                                                                                                                                  Page 
CHAPTER 2  INVESTIGATING THE SUITABILITY OF A  
LABORATORY MOUSE MODEL TO STUDY THE PATHOGENESIS OF 
ABORTIFACIENT CAMPYLOBACTER JEJUNI 
 Table 1      Number of pregnant mice, litter size, crown rump length  
 and number of mice producing live young for mice from which  
 there was high microbial recovery (TNTC) of C. jejuni IA3902  
 from the fetoplacental disc ................................................................................... 50 
 Table 2      Gross reproductive pathology for pregnant BALB/c  
 and CD-1 mice from which there was moderate and  
 high recovery (TNTC) of C. jejuni from the fetoplacental disc .......................... 50 
 Table 3      Sample source and semiquantitative recovery of  
 C. jejuni IA3902 cultured from pregnant BALB/c  
 and CD-1 mice at necropsy .................................................................................. 51 
      Table 4      Neutrophil scores of the fetoplacental discs with  
      high recovery (TNTC) of C. jejuni IA3902 in pregnant BALB/c  
    and CD-1 mice after oral and intraperitoneal inoculation ................................... 51 
      Table 5      Lectin histochemistry and special stains of  
     murine reproductive tissue ................................................................................... 52 
 
 
CHAPTER 3  THE USE OF A SERUM CYTOKINE ASSAY AND IN SITU 
HYBRIDIZATION TO EVALUATE PRO-INFLAMMATORY AND ANTI-
INFLAMMATORY CYTOKINES IN THE UTERUS AND PLACENTA OF 
CAMPYLOBACTER JEJUNI IA3902 INFECTED MICE 
 Table 1      Summary of infection for BALB/c and CD-1  
 pregnant mice used for serum cytokine testing following  
 oral and IP inoculation with C. jejuni IA3902 based on  
 microbial culture, gross pathology and histopathology ....................................... 78 
 Table 2      Summary of semiquantitative RNAscope
®
 scores  
 for cytokines evaluated within placental and uterine cells in  
 inoculated and control mice ................................................................................. 78 
 
 
CHAPTER 4     EVALUATION OF THREE DIFFERENT INOCULATION  
ROUTES FOR THE INDUCTION OF SHEEP ABORTION BY  
CAMPYLOBACTER JEJUNI CLONE SA 
       Table 1      Dose and animal distribution for the Pilot study and  
     Larger study ........................................................................................................ 102 
       Table 2      Pilot Study. Rectal temperatures,  
     fecal cultures and clone SA result by PCR at 0, 1, 2 and 7 DPI ......................... 102 
vii 
 
 
      Table 3      Pilot Study. Sample source and semiquantitative  
      recovery of C. jejuni IA3902 cultured from  
 pregnant ewes at necropsy ................................................................................... 103 
      Table 4      Larger study. Fecal and enriched culture data  
 for oral and IP inoculated ewes at 0, 4 and 11 DPI.............................................. 103 
      Table 5      Larger study. Sample source and  
      semiquantitative recovery of C. jejuni IA3902 cultured  
 from pregnant ewes at necropsy .......................................................................... 104 
      Table 6      Summary of clinical findings with microbiological,  
    histopathological and immunohistochemical correlates ...................................... 104 
      Table 7      Pilot Study. ELISA optical density (OD) 
     at 0 and 21 DPI for ewes inoculated by all routes ............................................... 105 
 
 
CHAPTER 5  MUCIN, L-FUCOSE, IRON, TOLL-LIKE RECEPTOR 4  
AND CASPASE 3 IN THE OVINE PLACENTA INFECTED WITH  
C. JEJUNI CLONE SA 
 Table 1      Final optimized conditions for incubation 
 times and Antigen Retrieval specifications for 
 Immunohistochemistry and Histochemistry procedures ...................................... 127 
 Table 2      Lectin histochemistry and special stains of  
 ovine reproductive tissue ..................................................................................... 127 
   
1 
 
CHAPTER 1:  GENERAL INTRODUCTION 
Statement of the Problem 
Campylobacter species colonize an extensive range of hosts including wildlife, 
pet and farm animals, are a frequent cause of gastrointestinal disease and are a zoonotic 
risk for humans.
53
 Evidence suggests that over the past decade there has been an 
increasing incidence of campylobacteriosis globally.
46
 A fast expanding, hypervirulent 
clone of Campylobacter jejuni (C. jejuni) has emerged, with the ability to cross the 
intestinal mucosa, enter the systemic circulation and cause abortion.
89
 This clone, C. 
jejuni clone SA (SA for Sheep Abortion), is now the primary agent of ovine abortion in 
the US, producing significant losses in sheep enterprises and has been documented to 
cause sporadic cases and outbreaks of gastroenteritis in humans.
70,90
  
Despite the increasing incidence of C. jejuni infection, the significant medical and 
economic consequences that can occur and the fact that the genome sequence of the 
organism is available, the cellular and molecular pathogenic mechanisms of disease are 
poorly understood.
73
  This is largely because there is a lack of suitable animal models that 
reliably and consistently replicate the pathophysiological and immunological responses in 
the gastrointestinal and reproductive systems of the infected host. The absence of 
appropriate laboratory models capable of consistently replicating the natural disease 
remains a significant impediment to the study of the reproductive pathology and abortion 
inducing capabilities of this new clone. A thorough and complete understanding of how 
and where C. jejuni localizes within the fetoplacental unit and knowledge of the precise 
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mechanism by which it produces fetoplacental compromise and abortion is currently 
unknown.  
Specific aims 
The ultimate aim of this research was to advance knowledge of the mechanisms 
of C. jejuni clone SA abortion. The hypotheses were that 1) Laboratory mice could be 
used as an animal model for C. jejuni-induced reproductive pathology studies (Chapter 
2); 2) Cytokines have an integral role in the abortion process and there is increased 
cytokine production from the murine fetoplacental tissue post infection with C. jejuni 
IA3902 (Chapter 3); 3) Oral, intravenous (IV) and intraperitoneal (IP) inoculation of 
pregnant sheep with C. jejuni will result in abortion (Chapter 4); 4) Apoptosis is a 
pathogenic mechanism of C. jejuni clone SA-induced abortion and indicators of apoptosis 
can be detected in the infected fetoplacental unit (Chapter 5) and 5) Toll-like receptor 4 
(TLR4) and transcription of nuclear factor kappa-light-chain-enhancer of activated B 
cells (NFκB) expression would be increased following ovine placental infection with C. 
jejuni clone SA (Chapter 5).  
To test these hypotheses four studies were conducted. In the first study, we set out 
to examine whether pregnant mice represent a suitable model in which to investigate the 
reproductive consequences of C. jejuni infection. Two strains of mice were challenged 
with C. jejuni clone SA via two routes (oral and IP) and gross and histopathological 
effects were determined. In the second study, the expression of six cytokines from C. 
jejuni infected murine placenta was measured to determine the role that cytokines may 
play in C. jejuni-induced reproductive disease. In a third study, which involved a pilot 
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and a second larger study, the pathology of C. jejuni clone SA (administered via the oral, 
IV and IP routes) on pregnant sheep was investigated, in an attempt to establish a reliable 
pregnant sheep model for C. jejuni clone SA abortion. In a final study, ovine placenta 
confirmed infected via microbial culture and immunohistochemistry (IHC) for the major 
outer membrane protein (MOMP), was assessed for the presence of apoptosis via a 
commercial assay and caspase 3 production as well as NFκB and TLR4 via IHC. Studies 
of apoptosis and presence of caspase 3 on infected ovine placenta were conducted to 
determine if these processes and enzymes played a role in abortion caused by the 
pathogen. As a component of the final study and to improve the understanding of the 
pathophysiology of C. jejuni clone SA we established the spatial localization of the 
organism in infected ovine placenta along with the presence of previously described 
trophic factors including mucin, iron and L-fucose. 
 
Dissertation organization 
The dissertation is composed of six chapters and organized in the alternative 
journal paper format. Chapter 1 is the introduction chapter. The subsequent four chapters 
(Chapter 2-5) are four individual manuscripts with the paper’s title as the main chapter 
heading.  Dr. Victoria Lashley, the PhD candidate, was the primary author of each 
manuscript. Chapter 6 is the final chapter with conclusions and considerations for future 
studies. References are located at the end of each chapter.  
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Literature review 
C. jejuni: Epidemiology and significance 
The genus Campylobacter is currently composed of 26 species, 2 provisional 
species and 9 sub-species.
46
 Campylobacter species are Gram-negative spiral, rod or 
curved bacteria without a flagellum, with a single polar flagellum or bipolar flagella 
depending on the species and are non-spore forming, approximately 0.2 to 0.8 by 0.5 to 5 
microns.
53,84
  C. jejuni is composed of two subspecies that differ significantly in their 
ubiquity and ecology, C. jejuni subsp. doylei for which there are no known animal hosts 
and C. jejuni subsp. jejuni which is normally referred to as simply C. jejuni.
48
   
C. jejuni is the most frequent cause of gastroenteritis in people in the developed 
world and despite measures to reduce intestinal colonization in poultry flocks and 
subsequent human infection, the incidence of infection has remained high.
78
  The US 
Centers for Disease Control and Prevention estimates that over 1.3 million people in the 
United States are infected every year with C. jejuni, resulting in 76 deaths annually.
73
  
Gastroenteritis caused by Campylobacter spp. in humans can arise from handling raw 
chicken meat or eating inadequately cooked chicken, having contact with pets and 
drinking or swimming in contaminated water.
33
  Interestingly, the organism can 
asymptomatically inhabit the gastrointestinal system of a large number of animal hosts, 
from production and companion animals to reptiles, wild birds and mammals and all 
these animals can serve as reservoirs of infection for humans.
28
  Even healthy dogs, 
particularly dogs under 2 of age years, shed Campylobacter spp. in their feces with C. 
jejuni being the second most frequent isolate detected.
37
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Commercial agricultural livestock operations provide unique ecological niches for 
a wide variety of Campylobacter genotypes.
85
  Production and livestock management 
systems appear to influence the selection of certain genotypes of C. jejuni. Research has 
demonstrated that the widespread use of the antibiotic tetracycline for the control of 
abortions in sheep has facilitated the selection of the highly pathogenic, tetracycline-
resistant, SA clone, at least in the US.
91
 Ovine gallbladder and intestinal colonization 
likely contribute to the occurrence of carrier ewes in the epidemiology of the disease on 
sheep production systems.
13,16
  
Multilocus sequence typing (MLST) and whole genome sequencing (WGS) are 
techniques that have enabled a deeper understanding of C. jejuni epidemiology and 
genetic evolution in influencing phenotypic variation of C. jejuni populations.
26,45
  
Colonization of multiple host species in divergent ecological niches can result in rapid 
adaptation of the genome of C. jejuni primarily by frame-shift mutations that alter gene 
expression or by horizontal gene transfer (HGT) which allows C. jejuni to acquire new 
genes from other bacteria.
74
 Research is discovering the pathogen in previously 
undocumented environments and species. Anthropic transfer of C. jejuni to sentinel 
marine wildlife species, namely, grey seal pups with histologic evidence of disease 
underscores the inherently complicated environmental, microbial and host relationships 
that exist with this pathogen.
9
 
The fact that the same organism can cause disease in different systems in different 
hosts definitely adds more complexity to the mix. The tetracycline resistant C. jejuni 
capable of causing abortion in sheep is genetically identical to isolates from human cases 
of gastroenteritis.
86
 People with gastroenteritis confirmed to be caused by this isolate had 
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a history of contact with cattle and farm environments.
21
  Further, while wild birds have 
been proven to contribute to a seasonal pattern of human campylobacteriosis,
22
 
associations with wildlife may be more difficult to investigate in abortion epizootics on 
sheep livestock operations.  
The organism has developed mechanisms to survive in the environment including 
the ability to enter a viable but non culturable (VBNC) state where it transforms from a 
motile spiral form to a coccoid form when subject to unfavorable conditions of low 
nutrient availability or suboptimal temperatures.
63
 Another mechanism is the formation of 
a biofilm, which in this instance is a composite of Campylobacter micro colonies bound 
together by an extracellular matrix in an attempt to form a less hostile microenvironment. 
C. jejuni has been isolated from aquatic biofilms with survival times of up to 42 days.
20
   
Recently, C. jejuni was categorized as a major antimicrobial resistant threat due to 
the increase in fluoroquinolone resistance and resistance to macrolide antibiotics which 
were previously the main drugs of choice for treatment.
21
 Antibiotic resistance, which is a 
global health challenge, has been caused by antibiotic overuse in the human population 
and in animal production systems for treatment, growth promoting effects and other off-
label uses.
54
 Campylobacter sp. display a number of antibiotic resistance mechanisms 
including alteration of the DNA gyrase target for fluoroquinolones; reduced membrane 
permeability due to MOMP and drug efflux via CmeABC for macrolides and acquisition 
of the tetracycline resistant gene (tetO) for resistance against tetracyclines.
42
 
Campylobacter acquire these resistance determinants by mutation and horizontal gene 
transfer (HGT) mediated by transduction, transformation and conjugation.
52
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In order to cause enteric disease, the organism must enter the gastrointestinal 
tract, survive the harsh acidic conditions of the stomach, colonize and multiply in the 
distal ileum and colon by using various motility, adhesion, cell invasion and cytotoxin 
production capabilities to overcome host defenses and cause diarrhea.
24
 It was reported 
that C. jejuni’s outer membrane proteins caused avian lymphoblast apoptosis suggesting 
that this was a pathogenic mechanism used by the organism.
93
 The ability of C. jejuni to 
activate apoptotic pathways in other cells and the role of this process in the pathogenesis 
of gastrointestinal and reproductive disease is unknown. Additionally, other possible 
mechanisms of reproductive tract infection and abortion induction by C. jejuni have not 
been fully elucidated and further research is urgently needed in this area. 
 
C. jejuni as a reproductive pathogen and cause of abortion  
The normal flora of the vaginal canal in domestic animals does not include C. 
jejuni.
40,51
 The organism can be harbored and shed intermittently in the feces of a wide 
range of wild and domestic animals and birds.
66
 C. jejuni is a frequent isolate in 
infectious abortion cases in ruminants, mainly in sheep causing ‘epizootic abortion’ and 
to some degree in cattle and goats.
69
 In sheep, Campylobacter generally causes late-term 
abortions with minimal clinical signs in the ewe prior to abortion.
35
  Infection is acquired 
via the ingestion of feed sources contaminated by feces or the products of abortion.
30,72,76
   
The ovine gastrointestinal tract is then colonized usually without diarrhea but with 
bacteremia in susceptible animals and subsequent infection of the uterus and placenta.
12
  
Since the organism is highly contagious, most pregnant ewes in the flock get infected 
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through ewes that abort during the current outbreak.
56
 Infected ewes that abort generally 
acquire immunity as abortions are generally not observed with subsequent infection.
59
  
C. jejuni abortions have been reported in 19% of 120 and 10% of 108 beef cattle 
herds in Canada.
83
 In that outbreak, cows were reported to have had placental retention 
and weight loss. C. jejuni was cultured in large numbers from infected bovine placenta 
and fetal tissues and this was accompanied by histologic changes of necrotizing, 
suppurative placentitis and fetal bronchopneumonia .
83, 88
 C. jejuni is also a documented 
cause of abortion in goats. There was diarrhea before or concurrent with abortions in 5/21 
goats from which C. jejuni was cultured from stomach content and various tissues from 
the aborted fetuses.
7
 
C. jejuni caused an outbreak of abortion (18%) on a Canadian mink ranch with 
29% of the breeding females also failing to conceive.
39
 In that outbreak, the organism 
was cultured from the liver of aborted fetuses, maternal feces and tissues including 
placenta, uterus and spleen. Abortion has been reported in experimentally infected ferrets 
which could not be prevented by acquired immunity from previous infection.
10
 
C. jejuni was isolated from canine placenta, fetal lung and liver and was reported 
as the cause of death in two adult female Bulldogs after fetoplacental infection with 
abortion and neonatal death.
69
 The organism was also isolated in from the profuse, 
odorless hemorrhagic, vaginal fluid from three German Shepherd bitches after late-term 
abortions.
62
 The pathogenesis of abortion in pregnant dogs has not been determined but 
may have a similar mechanism as in sheep as the organism can be carried 
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asymptomatically in the intestine of canines and is not an inhabitant of the vaginal flora 
of these species. 
17,62
 
In humans, C. jejuni infections during pregnancy have resulted in abortion, 
stillbirth, prematurity and neonatal sepsis.
75
 There has been some question as to whether 
C. jejuni as a placental pathogen in humans arises from ascending infection due to the 
presence of chorioamnionitis
25
 or to septicemia as in other species.
57,1
 For the most part, 
the reproductive pathology in humans and sheep are similar with foci of neutrophilic 
infiltration, peri-villous fibrin deposition with placental necrosis and eventual fetal 
death.
76
 
Pregnant guinea pigs abort after experimental infection with C. fetus, C. jejuni 
and C. coli and the pregnant guinea pig model was identified as a suitable and practical 
model for Campylobacter pathogenicity studies, regardless of the host of origin of the 
isolates.
77
 C. jejuni IA3902 is a representative isolate of clone SA and was determined to 
be a unique, highly abortifacient strain with the ability to colonize the intestines, cause 
systemic infection and induce abortion in pregnant guinea pigs due to its affinity for the 
fetoplacental unit.
18
 This highly pathogenic, tetracycline resistant clone has become the 
predominant cause of sheep abortions in the United States.
91
 The emergent strain is a 
zoonotic agent and retains its ability to cause gastroenteritis in humans in addition to 
producing significant economic losses for sheep producers.
90
 MOMP is the most 
abundant membrane protein in C. jejuni and functions as both a porin and an adhesin; is 
encoded by the porA gene, which has recently been determined to undergo specific amino 
acid substitutions in loop4 and it is this feature which is responsible for the systemic 
infection, hypervirulence and abortion inducing characteristics of C. jejuni clone SA.
89
 
10 
 
Animal models for the study of reproductive Campylobacter sp infection 
Enteritis caused by C. jejuni has been reported in young macaques, weaning-age 
ferrets, dogs, cats, pigs and chickens, rodents, and rabbits have been experimentally 
inoculated by various routes with C. jejuni.
48
 The animal model that most closely 
resembles gastrointestinal infection in humans is the oral infection model of nonhuman 
primates.
68
  Intestinal colonization has been established in a number of laboratory 
animals challenged with C. jejuni including infant mice, puppies and piglets and in these 
species, infection is usually chronic and almost always asymptomatic with intermittent 
excretion of the organism.
60
 
Despite the high prevalence of infection with C. jejuni, its significant medical and 
economic consequences, and knowledge of its genome sequence, the molecular and 
cellular mechanisms involved in the pathogenesis of this disease are not well understood 
due to a paucity of robust experimental animal models that mimic natural infection.
73
  
Replicating clinical symptoms of Campylobacteriosis in animal models have proved 
difficult when the animal model is different from the human host, when these models 
become cost prohibitive or when results are inconsistent.
8
 Acute enterocolitis is the 
typical outcome after infection with Campylobacter spp. in most mammalian species 
while meningitis, endocarditis and arthritis occasionally occur.
34
 In ruminants, 
reproductive pathology, specifically infertility and abortion, are the primary concerns.
23
 
Cellular alterations from trophoblastic invasion, bacterial products and products 
of the host inflammatory response
67
 during infection of the fetoplacental unit with C. 
jejuni clone SA likely all contribute to the reproductive pathology and abortion that 
11 
 
results. In the guinea pig placenta, a single layer of trophoblasts separates the fetal from 
the maternal circulation.
47
 As a result, infection of trophoblasts by C. jejuni from 
maternal vessels may be the path through which the organism can gain access across the 
fetoplacental barrier.  Similarly, there is only one layer of trophoblasts between the 
maternal blood and fetal vessels in the human placenta (labyrinthine 
hemomonochorial).
55
 On the contrary, the murine placenta is hemotrichorial with three 
layers of trophoblasts between the maternal blood and fetal vessels.
29
  
By the proposed natural oral route of infection, C. jejuni would have had to cross 
the intestinal barrier as well as the fetoplacental barrier to cause eventual fetal infection.  
While some intestinal pathogens disrupt tight junctions and others actively cross 
enterocytes to cause gastrointestinal infection,
36
 the exact mechanism by which 
pathogens cross the placental barrier and infect the fetus are often elusive.
27
   
In pregnant guinea pigs, C. jejuni IA3902 spares the main placenta and is present 
within subplacental trophoblasts at the circumference of the junctional zone close to the 
site of placental vascular invasion.
18
 The pregnant guinea pig model is used in 
vaccination efficacy studies
14,15
 and to screen for virulence of C. coli, C. fetus and C. 
jejuni.
23
 Additionally, abortion in guinea pigs is used as an indicator of Campylobacter 
pathogenicity.
77,81
 Currently, no other model has been able to replace the pregnant guinea 
pig for reproductive studies with C. jejuni due to the ease of reproducibility of abortion, 
ease of handling and housing of the animal, ability to use various routes of administration 
along with the short gestation of the guinea pig. 
12 
 
The ovine placenta is chorioallantoic, adeciduate, cotyledonary, villous and with 
an interhemal barrier described as synepitheliochorial.
31
  The susceptibility or resistance 
of the barrier structure of the ovine placenta to bacterial infection is unknown. Gross 
lesions reported in sheep experimentally infected with C. jejuni include abortion, still 
birth, uterine prolapse and retained placenta with histological lesions of necrosuppurative 
placentitis and/or endometritis.
35,71
 Published reports of experimental studies in sheep are 
limited and a fully reproducible ovine model has not been comprehensively described. 
The associated housing costs, high frequency of natural gallbladder and gastrointestinal 
colonization, challenges associated with securing specific-pathogen-free or naïve 
pregnant ewes and the relatively long gestation in these animals are some of the major 
obstacles hindering research advancement in the target species.  
 
C. jejuni, cytokines, apoptosis, TLR4 and NFκB  
Cytokines are small proteins that regulate cells by binding to receptors present on 
target cells.
82
 Receptor binding triggers intracellular signaling, altered gene expression, 
and the production of other cytokines, surface receptors or feedback inhibition.
43
  
Cytokines function locally and systemically and are classified as chemokines, 
lymphokines, or interleukins based on target action, cell of secretion or function.
64
 They 
regulate physiologic and pathologic processes involved in innate and acquired immunity, 
inflammatory responses and hematopoiesis and are produced by many types of cells.
49
 
While cytokines are generally not stored intracellularly, their levels may be amplified, 
attenuated or they may initiate the secretion of other mediators, especially when there is 
13 
 
inflammation within the affected organ or tissue.
58
 Analysis of cytokine profiles can aid 
investigations into host-pathogen interactions, bacterial persistence and bacterial 
clearance from infected hosts.
32
 
Central to the ability of C. jejuni to cause gastrointestinal disease is that it induces 
the production of pro-inflammatory cytokines.
87
 Cells produce cytokines when C jejuni 
binds to lipoprotein JlpA, a C. jejuni surface protein, which interacts with host cell heat 
shock protein, Hsp90, to activate NFκB via mitogen-activated protein (MAP) kinases, 
ERK and p38 intracellularly.
6
 Additionally, the dysregulation of pro-inflammatory and 
anti-inflammatory cytokines post infection with C. jejuni may cause increased 
susceptibility to enteritis.
61
 
Systemic infection of C. jejuni in BALB/c mice was associated with the initial 
production of pro-inflammatory cytokines, TNF, IL1 and IL2 and subsequent production 
of anti-inflammatory cytokines IL4 and IL10 in the spleen and large intestine.
5
 In that 
same study, it was found that once the systemic infection had been cleared, the cytokine 
response was predominantly anti-inflammatory and associated with the production of IL4 
and IL10 in the liver and small intestine.  Interestingly, even mucin expression in 
reproductive tract epithelia may vary in response to cytokine influences.
11
 TNFα, IL 4 
and IL13 can upregulate mucin expression via increased MUC2 transcription through 
NFκB activation.44 C. jejuni is chemotactic for and has enhanced growth in the presence 
of mucin.
19
 Therefore the cytokines produced as a result of C. jejuni infection are capable 
of enhancing the growth of the pathogen within the fetoplacental unit. 
14 
 
Trophoblasts produce cytokines 
41
 and altered cytokine profiles are characteristic 
of numerous disorders of gestation.
65
 Murine abortion was induced after Listeria 
monocytogenes infection significantly upregulated trophoblast pro-inflammatory cytokine 
production.
50
 Sheep placenta infected with C. jejuni SA had increased expression of 
cytokine genes which were likely involved in inflammation and necrosis.
71
 The cytokines 
produced from a C. jejuni infected sheep placenta and the role of these cytokines in the 
pathophysiologic processes of the associated reproductive pathology and abortion are 
currently unknown.  
TLRs are pattern recognition receptors that recognize specific, highly conserved 
pathogen-associated molecular patterns and play a key role in innate immune defense.
4
  
TLRs in mammals function to detect specific components of bacterial, fungal and viral 
pathogens.
80
 TLR4 is essential for detecting lipopolysaccharide (LPS), a major 
component of the outer membrane of Gram-negative bacteria
38
 like C. jejuni. LPS can 
elicit potent immuno-stimulatory activity by excessive activation of monocytes and 
macrophages leading to endotoxic shock.
79
 TLR4 is present in placenta
92
 and is highly 
expressed in trophoblasts.
2
 Intrauterine infection has been linked to increased trophoblast 
apoptosis and it was demonstrated that TLR mediated apoptosis was partly due to the 
activation of caspase 3.
2
 Trophoblasts recognize and respond to pathogens through the 
expression of TLRs.  Since C. jejuni infects and resides in trophoblasts, the TLR-
mediated trophoblast response could significantly direct pregnancy outcome
3
 in a C. 
jejuni infected placenta.
35
 
The roles of altered pro-inflammatory and anti-inflammatory cytokines, the 
process of apoptosis, the activation of TLR4 and production of NFκB in C. jejuni 
15 
 
infection in the reproductive tract and specifically the infected fetoplacental unit require 
further investigation in order to determine the potential significance of these in the 
pathophysiology of abortion induced by the pathogen. 
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Abstract 
The aim of this study was to assess whether pregnant mice represent a useful 
model to study the reproductive pathology of Campylobacter jejuni (C. jejuni) IA3902 
using the endpoint of positive microbial culture of the organism from the fetoplacental 
unit. Pregnant BALB/c and CD-1 mice (14 days gestation), were inoculated orally with 
0.5 ml (1x10
9
 colony forming units CFU/ml) and intraperitoneally (IP) with 0.1 ml 
24 
 
(1x10
9
 CFU/ml) of C. jejuni IA3902. The organism was recovered by microbial culture 
from the fetoplacental unit in 10 out of 10 (10/10) (100%) BALB/c and 10/10 (100%) 
CD-1, IP inoculated pregnant mice and in 2/7 (29%) BALB/c and 3/8 (38%) CD-1 orally 
inoculated pregnant mice. Gross reproductive pathology included necrosuppurative 
placentitis, fetal resorption, intrauterine fetal death, dead (stillborn) pups and maternal 
multifocal hepatitis. Histological fetoplacental changes consisted of locally extensive 
neutrophilic and necrotizing placentitis with intralesional bacterial colonies of C. jejuni; 
ulcerative endometritis and random multifocal hepatitis with rare cholecystitis in the dam. 
Immunohistochemistry for the major outer membrane protein (MOMP) of C. jejuni 
revealed moderate to large numbers of the organism at the periphery of the placental 
discs within trophoblasts and extracellularly with invasion into the placental disc largely 
via the vascular network. The organism is trophic for neutral mucin, iron and L-fucose 
within the murine placenta. C jejuni IA3902 has affinity for the murine reproductive 
tract, specifically the fetoplacental unit, where it results in a necrotizing placentitis with 
positive microbial recovery after both IP and oral challenge in BALB/c and CD-1 
pregnant mice.   
 
Keywords 
Campylobacter jejuni, histopathology, immunohistochemistry, laboratory mice, 
placentitis, reproductive pathology 
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Introduction 
C. jejuni is a small (0.2-0.9 µm wide and 0.2-5.0 µm long), spiral, Gram-negative 
bacteria, principally known as a zoonotic pathogen.
15
 The organism is non-spore forming, 
but vigorously motile by means of a single polar flagellum at one or both ends, it’s most 
studied virulence determinant.
29
 Campylobacter related infections are leading causes of 
foodborne bacterial disease in humans and reproductive loss in sheep with abortion rates 
that range from 5% to 50% in infected flocks.
22,31
 C. jejuni colonizes the gastrointestinal 
tract of a wide range of animals that act as reservoirs of infection by fecal shedding. 
Insights into the molecular mechanisms of disease and immunopathogenesis have been 
severely limited due to the absence of convenient murine infection models. 
Historically, murine models of C. jejuni infection have been limited by sporadic 
colonization and/or absence of clinical disease.
4
 C. jejuni resistance in mice is likely 
influenced by continuous active competition from resident intestinal microbiota that 
outcompete C. jejuni for survival and tolerance of the murine immune system to C. 
jejuni.
27
 A murine model for the study of C. jejuni abortion is needed to reduce research 
costs compared to the commonly used guinea pig. Additionally, the reproductive system 
of the laboratory mouse has been extensively studied.  Mice have a hemochorial placenta 
similar to humans, a short gestation period, defined genetics and their immune system has 
been well characterized and is similar to that of humans.
10
 The mouse model has proven 
useful for the study of the pathogenesis of reproductive disease due to Chlamydophila 
abortus and vaccine related investigations 
9
 and a pregnant mouse model has been 
characterized for the study of bovine Tritrichomonas fetus infection.
1
 Murine models 
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have been established for human reproductive research as a mouse model for 
preeclampsia has been described.
2
  
Several studies have demonstrated that abortion can be reliably produced in 
guinea pigs following either oral or intraperitoneal inoculation of C. jejuni.
6,7
 Despite 
routine recovery of C. jejuni from naturally aborted ovine fetuses, there has been limited 
success reproducing abortion in experimentally infected pregnant sheep, the species in 
which reproductive loss is of greatest concern. There have been no published reports of 
the reproductive pathology of C. jejuni in mice, which, because of their size, ease of 
handling and availability of various reagents, are the most commonly used laboratory 
research animal model.  The mouse model has been used by some researchers to study 
other aspects of Campylobacteriosis and it has been demonstrated that bacteremia is a 
very common and consistent finding, which is an essential step in the pathogenesis of 
abortion.
30
  Mice have also been used in several vaccination studies,
17,21
 including those 
against reproductive bacterial pathogens.
12,14
 The purpose of this study was to investigate 
whether mice represent a useful research model to assess the reproductive pathogenicity 
of C. jejuni. 
 
Materials and Methods 
Mice: 30 BALB/c mice (24 females and 6 males) and 30 CD-1 mice (24 females 
and 6 males), 6-8 weeks old were sourced from a commercial supplier and acclimated for 
5 days. Mice were kept in isolator cages in groups of 4 in an infectious disease 
containment room with autoclaved wood chip bedding and fed a commercial pelleted 
27 
 
mouse diet and water ad libitum. Four female mice were group housed with a male of the 
same species for 14 days. On day 15, female mice were bled (0.1-0.2 ml blood collected 
from the saphenous vein using a 25G needle), inoculated with C. jejuni IA3902 and 
housed in individually identifiable cages for observation twice daily for one week. There 
were 4 control mice per strain. All mice were humanely euthanized one week post 
inoculation with 0.1-0.2 ml ketamine/xylazine solution (80/16 mg/kg) via intraperitoneal 
injection using a 25 G needle followed by exsanguination. At necropsy, cardiac blood 
was collected for serum testing.  Uterus, placenta, fetal tissues and maternal liver were 
collected for histopathology and blood, uterine contents and cecal swabs were collected 
for microbiology. 
C. jejuni IA3902 inoculum: 0.5ml (1x10
9
 CFU/ml) was administered once, orally and 
0.1ml (1x10
9
 CFU/ml) was administered once IP.  
 
Experimental design 
The reproductive pathology of C. jejuni IA3902, a clinical isolate of clone SA, 
was assessed after either oral or intraperitoneal inoculation in two strains of mice. Sixty, 
7-8 week old mice, 30 outbred CD-1 (24 female and 6 male) and 30 inbred BALB/c mice 
(24 female and 6 male) were purchased from a commercial source. They were acclimated 
for 5 days before use. Four female mice were group housed with a male of the same 
species for 14 days for breeding.  On day 15, all study animals were bled and inoculated 
with abortifacient C. jejuni IA3902. 0.1-0.2 mls of blood was collected from the lateral 
saphenous vein using a 25 G needle. Mice were placed head first into a 50 ml centrifuge 
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tube with a 1 cm diameter whole in the conical end for restraint which allowed access to 
the animals rear legs, the hair was shaved from the lateral aspect of the leg using a small 
electric clipper, petroleum jelly was lightly rubbed onto the skin, the vein was gently 
pricked with the needle and blood was collected by capillary action into a hematocrit 
tube. After collection a sterile gauze pad was gently pressed over the puncture site to stop 
bleeding. Ten female mice of each strain were inoculated orally after a 12 hour long feed 
withdrawal. Mice were lightly anesthetized via gaseous anesthesia in an anesthetic 
chamber with 2 % isoflurane and then quickly removed, and inoculated orally with 0.5 
mls of C. jejuni IA3902 at 10
9
 CFU/ml, via gastric lavage using a stainless steel, ball-
tipped 24 gauge (G) 1.0 inch animal feeding tube. Ten female mice of each strain were 
inoculated IP. Each mouse was briefly placed on its back with its head tilted slightly 
downward and 0.1 ml of C. jejuni IA3902 at 10
9
 CFU/ml injected IP using a 25G needle. 
After inoculation female mice were immediately housed in individually identifiable cages 
for observation twice daily for one week. For each group, there were 4 control (non-
inoculated) female mice per strain also housed individually.   
Over the subsequent week, all mice were monitored twice daily for clinical signs 
of inactivity, unresponsiveness, ruffled hair coat, diarrhea, vaginal discharge and abortion 
(fetal loss). All mice were humanely euthanized one week post inoculation. For 
euthanasia, mice were rendered completely unconscious using 100-200 µl IP 
Ketamine/Xylazine (80/16 mg/kg) administered IP with the mouse briefly placed on its 
back with head tilted slightly downward. This produced deep anesthesia and was 
followed by exsanguination, after the mouse became unconscious, as determined by loss 
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of righting reflex (body movement) and/or unresponsiveness to noxious stimuli and in 
accordance with AVMA Guidelines for Euthanasia of Animals, 2013 edition.  
At the time of necropsy, the following samples were collected: heart blood for 
serum collection and bacterial culture, cecal swab, uterus and uterine contents (placenta 
and fetus) for bacteriology and maternal liver with gallbladder, uterus and uterine 
contents for histopathology. The study was approved by Institutional Animal Care and 
Use (IACUC), protocol 5-15-8018-M and fully compliant the regulations of the 
Laboratory Animal Resources (LAR) group of Iowa State University (ISU), at whose 
facility the study was undertaken.  Appropriate personal protective equipment was worn 
when mice were inoculated, samples collected and necropsy performed both in the 
animal treatment and in the necropsy rooms.  
 
Necropsy, microbial culture and histopathology 
All mice were subjected to a complete necropsy. At necropsy, all gross lesions 
were noted and samples collected for microbial culture and histological examination. 
Cecal swabs were obtained using sterile minitip cotton swabs with transport media 
immediately after euthanasia. Uterus, placenta and fetal tissue were harvested in sterile 
petri dishes for Campylobacter culture. All samples for microbial culture were 
refrigerated immediately upon collection and plated on the day of collection. Rectal 
swabs and blood were directly streaked onto culture media. Uterus and fetoplacental 
tissue were minced, swabbed and streaked onto Mueller-Hinton (MH) agar containing a 
Campylobacter selective supplement (polymyxin B, rifampicin, trimethoprim and 
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cycloheximide) and a Campylobacter growth supplement (sodium pyruvate, sodium 
metabisulfite and ferrous sulfate). Plates were incubated for 48 hours in anaerobic jars 
under micro aerobic conditions at 42 
o
C. Campylobacter colonies were counted on each 
plate to determine the number of colony forming units (CFU) in each sample. 
Uterus, fetoplacental unit, placenta, liver and gallbladder were examined 
histologically. Tissues were fixed in 10% neutral buffered formalin for 24 hours. 
Preserved tissues were paraffin embedded and 5-7 micron sections were mounted on 
slides and routinely stained with hematoxylin and eosin.  
 
Neutrophil scoring of reproductive lesions 
The mean number of neutrophils present in five fields (40X magnification) was 
assessed for each of four locations in the reproductive tissue including, the periphery and 
parenchyma of the placental disc, the uterine wall and uterine lumen. Neutrophil counts 
were scored for each location using the following criteria (1= <10 neutrophils/hpf; 2=11-
25 neutrophils/hpf; 3=26-50 neutrophils/hpf and 4= >51 neutrophils/hpf). 
 
Histochemistry 
Lectin   
Three micron (3 µm) serial sections were set on aminoalkylsilane-coated glass 
slides, baked at 56 
o
C for 2 hours and routinely deparaffinized in xylene and rehydrated 
in graded alcohol solutions and water baths. Endogenous peroxidase inhibition was 
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achieved by immersion (2 immersions; 10 min/immersion) in baths of 3% hydrogen 
peroxide (H2O2) in water. Antigen was unmasked by treating sections with Tris-EDTA 
(pH 9.0) in a stream bath for 20 minutes, cooled to room temperature, and rinsed 3 times 
in phosphate buffered saline (PBS) prior to placement in an automated cell staining 
system (BioGenex, US). The lectin used was the commercially available biotinylated 
Lotus tetragonolobus lectin agglutinin I (LTA; Vector, US) applied to sections at 20 
mg/ml and incubated at 22 
o
C for 30 minutes, followed by rinsing in a bath of PBS 
solution for 5 minutes. Lectin binding was visualized using a commercial kit (Vectastain 
Elite ABC, Vector) and chromogen (NovaRED, Vector) as per the manufacturer’s 
instructions; the sections were then counterstained with hematoxylin and mounted 
routinely. Specificity of lectin binding was confirmed by preabsorbing lectins in 250mM 
of L-fucose prior to application to serial sections. Negative controls were prepared from 
serial sections with the lectin omitted and replaced with dilution buffer. Lectin binding 
was subjectively quantified in the fetoplacental unit, uterus and yolk sac (visceral and 
parietal layers) as low/absent, moderate or abundant in random 40X magnification fields 
and classified as to whether staining was cytoplasmic or membranous. 
 
Special stains 
Perls’ iron stain, Alcian blue pH 2.5 and the Periodic acid-schiff (PAS) reaction 
without diastase pretreatment were performed on twelve sections randomly drawn from 
each of the groups along with one control mouse slide. Serial sections were cut to 5 µm, 
stained and assessed to determine the presence of absence of material with characteristics 
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consistent with iron, acid mucin and neutral mucin within the fetoplacental unit, yolk sac 
(visceral and parietal layers) and uterine wall. Staining was subjectively classified as 
low/absent, moderate or abundant, intracellular, extracellular, multifocal or diffuse. 
 
Immunohistochemistry 
Placental discs collected at necropsy were processed, embedded and sectioned at 
3 microns, mounted on aminoalkylsilane-coated glass slides and baked for 2 hours at  
56 
o
C. Slides were deparaffinized routinely in xylene and rehydrated in graded alcohol 
solutions and water. Inhibition of endogenous peroxidase was via 2 immersions for 10 
mins each in 3% H2O2 in water. Slides were incubated for 15 minutes at 37 
o
C in 0.1% 
protease in Tris buffer of pH 7.6, then rinsed 3 times in PBS solution and stained 
automatically. Nonspecific binding was inhibited by incubation with 10% neutral goat 
serum at 22 
o
C for 20 minutes. The primary antibody was directed against the MOMP of 
C. jejuni, as described by Zhang et al 
32
 at a dilution of 1:300 and incubated at 22 
o
C for 
60 minutes and then rinsed in PBS for 5 minutes. A commercially available biotinylated 
secondary antibody was used at a dilution of 1:80 and incubated at 22 
o
C for 15 minutes 
then rinsed in PBS for 5 minutes. Slides were then incubated with horse radish 
peroxidase-streptavidin conjugate at 22 
o
C for 15 minutes and rinsed in PBS for 5 
minutes. The final reaction used a commercial chromogen. Slides were rinsed and 
routinely counterstained with Shandon Harris hematoxylin and Scott’s tap water. Slides 
were dehydrated through graded alcohol and xylene solutions prior to mounting. Positive 
controls were sourced from paraffin blocks of ovine placenta that was positive for  
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C. jejuni IA3902 by microbial culture. Negative controls were from un-inoculated mice 
in the study. 
 
Statistical analysis 
A commercial statistical software package, SAS 9.4 version was used to perform 
a nonparametric Kruskal-Wallis test to detect differences in mean neutrophil scores 
among inoculation routes (BALB/c Oral, BALB/c IP, CD-1 Oral, CD-1 IP and control) 
and for different locations (placenta periphery and parenchyma, uterine lumen and wall) 
in mice with C. jejuni isolated from placenta and uterus by microbial culture. Secondly, 
the same nonparametric Kruskal-Wallis test was performed to test if different placental 
culture levels (level 0=no CFU, level 1=<50 CFU, level 2=50-1000 CFU, level 3=TNTC) 
impacted neutrophil scores at the placental periphery and in the placental parenchyma, 
and if different uterine culture levels impacted neutrophil scores for the uterine lumen 
and uterine wall. Results were considered significant at values of p ≤ 0.05. 
 
Results 
There were 14 mice from which there was high microbial recovery (TNTC) of C. 
jejuni IA3902 from the fetoplacental discs, including 3 orally inoculated mice (1 BALB/c 
and 2 CD-1) and 11 IP inoculated mice (4 BALB/c and 7 CD-1) (Table 1). For mice with 
infected fetoplacental discs, while there did not appear to be any obvious effect on litter 
size or crown-rump length as compared to control mice, there was a significant decrease 
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in the birth of live young with 93% of mice with infected fetoplacental discs failing to 
produce live young.    
Gross reproductive pathology (Table 2) ranged from the birth of term dead pups 
(stillborn mice found in cage), intrauterine fetal death (tan/white mid-sized conceptus) 
and placentitis (edematous and hemorrhagic, yellow or green placental discs) (Figure 1) 
and fetal resorption (placental disc without macroscopic evidence of a subjacent fetus) 
(Figure 2). 
At necropsy, gross evidence of fetoplacental infection was found only in animals 
from which C. jejuni IA3902 was isolated in moderate and high counts from the 
fetoplacental disc, with 100% correlation between the presence of gross reproductive 
pathology at necropsy and the microbial recovery of moderate to high counts of C. jejuni 
IA3902. When there was high recovery (TNTC) of C. jejuni from the fetoplacental discs, 
BALB/c mice inoculated IP displayed all four gross changes at necropsy including dead 
pups, dead fetuses, fetal resorption and placentitis. Both BALB/c and CD-1 mice 
demonstrated gross evidence of placentitis after intraperitoneal inoculation with the 
BALB/c strain having placentitis after oral inoculation with high recovery of the 
organism from infected fetoplacental tissue. One CD-1 mouse had intrauterine fetal death 
with moderate recovery (50-1000 CFU) of C. jejuni from the fetoplacental disc following 
oral inoculation.  Control mice of both strains did not have dead pups, dead fetuses, and 
gross or histological evidence of fetal resorption or placentitis. 
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There were rare, 1 mm wide white foci on the liver of two BALB/c mice, from which the 
organism was positively identified by culture. One of these mice was inoculated IP 
(>1000 CFU) and the other was orally inoculated (50-1000 CFU). 
 
Microbial culture Results 
C. jejuni IA3902 was cultured from cecal swabs at necropsy from all challenged 
mice except 2 CD-1 mice, (one was orally inoculated and the other was inoculated IP). 
The organism was cultured more often and in much higher numbers from the placenta 
than from the free uterine wall, irrespective of strain of mouse or route of administration. 
The organism had an affinity for the murine fetoplacental unit as it could be cultured 
from the fetoplacental unit of every single mouse (all 10 BALB/c and all 10 CD-1 mice) 
inoculated intraperitoneally. Heavy bacterial growth (>1000 CFU or TNTC) from the 
fetoplacental disc was detected in CD-1 mice twice as often as in BALB/c mice. After 
oral inoculation in both mouse strains recovery of C jejuni IA3902 from the fetoplacental 
unit was possible in 2/7 BALB/c mice (1 at < 50 CFU and 1 at >1000 CFU) and 3/8 CD-
1 mice (1 at 50-1000 CFU at 2 at >1000 CFU) (Table 3). 
 
Histopathology, histochemistry and immunohistochemistry 
Histologically, the uterine lesions of C. jejuni IA3902 inoculated pregnant mice 
consisted of multifocal areas neutrophilic infiltration, endometritis, endometrial 
ulceration, necrosis and occasional hemorrhage. There was a neutrophilic placentitis with 
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moderate to large numbers of neutrophils disrupting cellular integrity primarily along the 
periphery of the placental disc. Within these foci at the periphery of the infected placental 
discs, there were variable amounts of necrotic cellular debris and hemorrhage with 
occasional bacterial colonies 150-250 microns in diameter. 13/14 mice that had high 
recovery (TNTC) of C. jejuni IA3902 by microbial culture from the fetoplacental discs 
also had increased numbers of neutrophils within the periphery of the fetoplacental disc 
(neutrophilic placentitis) (Table 3). There were variable numbers of neutrophils within 
the uterine lumen and endometrium of the 4 non-pregnant mice (3 BALB/c mice and 1 
CD-1 mouse that were all orally inoculated) with rare ulcerative endometritis. C. jejuni 
was not cultured from the uterus of these mice. 
Inoculated mice that gave birth prior to the study termination and from which  
C. jejuni was isolated had moderate to large numbers of neutrophils present within the 
submucosa and endometrial glands and erythrocytes within the uterine lumen. 
Postpartum control mice had low numbers of neutrophils and erythrocytes within the 
uterine lumen and submucosa.   
There was a significant difference in neutrophil scores between inoculation routes 
for the uterine lumen (p value 0.0159), where neutrophil scores from BALB/c mice 
inoculated IP, which had the highest mean score (34.15), were significantly higher than 
the controls, which had the lowest mean neutrophil score (18.00). Also there was a 
significant difference among inoculation routes for neutrophil scores in the uterine wall 
(p value 0.0057), where BALB/c inoculated orally had significantly higher mean 
neutrophil score (31.80) compared to the control which had the lowest mean neutrophil 
score (10.50).  
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Culture of higher levels of C. jejuni from tissues was typically associated with a 
more pronounced inflammatory response as measured by neutrophil scores. The mean 
neutrophil score at the placental periphery (10.85) was significantly higher (p value 
0.0049) when numerous Campylobacter (level 3) were isolated from the fetoplacental 
disc (Table 4) when compared to the mean neutrophil score (3.00) when no organisms 
were isolated (level 0). Similarly, neutrophil scores for the uterine lumen at microbial 
culture level 1 (score 18.0, p value 0.0028) and microbial culture level 2 (score 14.0, p 
value 0.0028), and the uterine wall at microbial culture level 3 (16.25, p value 0.0089) 
were significantly higher than neutrophils scores at these locations with microbial culture 
level 0 had mean neutrophil score 5.0 in the uterine lumen and 5.5 within the uterine 
wall.  
The spatial distribution of mucin, iron and L-fucose within the murine placental 
unit and adjacent tissue was assessed for all murine fetoplacental discs (Table 5). In 
sections stained with PAS, which stains neutral mucins, there was moderate to abundant 
globular staining in the placental disc and yolk sac, within the cytoplasm of trophoblasts 
and yolk sac cells (intracellularly) and extracellularly (Figure 3). Alcian blue staining, 
which stains acid mucins, was absent to low. Iron was present multifocally within the 
parenchyma of the placental disc, mainly within vascular sinusoids (Figure 4). Lectin 
histochemistry for LTA, demonstrated moderate to abundant, multifocal, cytoplasmic and 
membrane staining of cells of the yolk sac, uterine mucosa and extracellular staining at 
the periphery of the placental disc (Figure 5). 
Histologically, the white foci on the liver of the two BALB/c mice, one inoculated 
IP and the other inoculated orally, presented as random multifocal necrotizing hepatitis 
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and mild lymphoplasmacytic cholangitis. Rarely, there were increased numbers of mixed 
inflammatory cells within sinusoids and in the submucosa and the mucosa of the 
gallbladder (cholecystitis). 
Immunohistochemistry for MOMP was performed on five placental samples, one 
sample drawn from each of the four groups in which positively identified by microbial 
culture and one control. Staining for C. jejuni was completely absent in the control slide, 
but was positively identified within each of the four murine fetoplacental discs from 
which high numbers of C. jejuni were isolated.  Positive staining was present within the 
cytoplasm of trophoblasts mainly at the periphery of the placental disc, within neutrophils 
and extracellularly in vascular sinusoids of severely affected placental discs (Figure 6).  
 
Discussion 
Several animal models for intestinal Campylobacteriosis have been investigated 
including an oral ferret, piglet, rabbit, chick/avian and SCID mouse model,18  while the 
pregnant guinea pig has been the primary model for reproductive studies. In spite of over 
30 years of research, there is no consensus on a widely acceptable animal model for 
human intestinal and reproductive Campylobacteriosis research. Mice are the most 
commonly used animal to study genital chlamydial infections with two established 
murine models in which the course of disease and outcome can be varied depending on 
the mouse strain, inoculating dose, age of the mice and levels of reproductive 
hormones.19  
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There are several reasons why establishing a murine model for reproductive 
studies with C. jejuni IA3902 would be useful. These include the fact that mice are the 
lowest species on the phylogenetic tree that can be used appropriately to investigate the 
viability of a reproductive model and both the murine and human placenta is discoid and 
hemochorial, which supports a similar pathogenesis in reproductive disease studies. 
Murine models have already been defined for various infectious agents and vaccine 
studies and bacteremia has already been demonstrated to be a common and consistent 
finding with Campylobacteriosis.30 Murine studies would also be ideal for elucidating the 
genetic factors involved in host defense against C. jejuni infection as there are murine 
models with defined deletions for components of innate and adaptive immunity.16 
Additionally, experiments in pregnant mice have demonstrated that Campylobacter sp. 
can translocate from a distant site of infection to the placenta to induce adverse effects on 
the fetus and placenta.3 
There was a significant decrease in the birth of live young from mice with C. 
jejuni infected placentas as 93% of mice with heavily infected fetoplacental discs failing 
to produce live young. There was also a high correlation between the presence of gross 
reproductive pathology at necropsy and microbial recovery of moderate to high counts of 
C. jejuni IA3902. This is similar to what has been demonstrated in guinea pigs. 
Abortions, while not observed in this study, occurred in 6/12 pregnant guinea pigs within 
4 and 10 days post oral inoculation with C. jejuni IA3902.7 The short gestation in mice 
(18-22 days), dose and time of inoculation and the relatively short interval between 
challenge and necropsy may have precluded abortions from being observed in this study. 
Stillbirths have been reported as part of the reproductive pathology associated with C. 
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jejuni IA3902 infection in sheep.
22
 This was also a finding in infected mice in this study 
but has not been reported in experimentally infected guinea pigs. Fetal resorption has 
been reported in pregnant mice after administration of lipopolysaccharide (LPS)
24,20
 and 
was seen in this study.  
In two BALB/c mice, there was random multifocal hepatitis grossly and 
histologically with microbial recovery of the organism from hepatic tissue, in addition to 
cholecystitis. Multifocal hepatitis has also been reported with pregnant guinea pigs 
inoculated with C. jejuni IA3902,7  and in both species is likely associated with the 
bacteremia that precedes fetoplacental infection.  
Exudation of leukocytes is a feature of the reproductive tract infection with 
Campylobacter.
13
 In this study, there was a statistically significant neutrophilic infiltrate 
within the endometrial wall (endometritis). This is in agreement with sheep studies using 
this pathogen, where histopathological lesions included suppurative necrotizing 
placentitis and/or endometritis23 and also in agreement with guinea pig studies where 
uterine lesions, though variable, consisted of suppurative endometritis, metritis and 
hemorrhage.7 
 There were variable numbers of neutrophils (scores between 2 to 4) accompanied 
by rare ulcerative endometritis within the endometrium of challenged mice that were not 
pregnant at study termination. The organism was not recovered by culture from this 
location in these animals one week post inoculation, at necropsy. In comparison, in non-
pregnant guinea pigs, the organism was cultured at low levels (<50 CFU) from the uterus 
in 2/11 (18%) animals two days post inoculation.
6
 It is notable that in the guinea pig 
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study all animals were challenged IP, the study was terminated at a much shorter interval 
of 48 hours post challenge and only low bacterial counts were detected in only 2 guinea 
pigs. Based on histologic changes, it appears that in mice, as in guinea pigs, C. jejuni is 
trophic for the uterus even in non-pregnant animals.  
Within the C. jejuni infected fetoplacental unit, there was a neutrophilic 
placentitis with moderate to large numbers of neutrophils disrupting cellular integrity 
primarily along the periphery of the placental disc with necrotic cellular debris and 
hemorrhage and bacterial colonies 150-250 microns in diameter.  Neutrophilic placentitis, 
a feature of the reproductive tract infection in pregnant guinea pigs,
7
  was also a 
consistent and reliable feature in infected fetoplacental tissue irrespective of mouse strain 
or route of infection. High neutrophil scores correlated with microbial recovery from 
heavily infected fetoplacental discs, as 12/13 mice (92 %) from which C. jejuni IA3902 
was recovered in high counts (TNTC), neutrophils scores were 2 or higher. There was a 
significant difference among placental microbial culture levels for neutrophil scores for 
the placental periphery (p value 0.0049) where level 3 (TNTC microbial culture) had a 
higher mean neutrophil score than level 0 (control with no microbial growth). 
The proposed pathogenesis for Campylobacter abortion is oral ingestion followed 
by intestinal colonization and translocation, bacteremia, and infection of the fetoplacental 
unit.11,25,26  In both strains of mice, C. jejuni IA3902 could be isolated from the blood, 
uterus and fetoplacental unit after oral inoculation which supports the suitability of the 
model as it demonstrates replication of the natural disease with bacteremia resulting from 
intestinal invasion with subsequent infection of the fetoplacental tissue.  However, in 
both strains of mice evaluated, the percentage of animals with demonstrable fetoplacental 
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infection following oral inoculation (29% for BALB/c and 38% for CD-1) was 
considerably lower than is typically observed in guinea pigs following oral challenge 
(70%).
7
 Though less desirable for the study of the overall pathogenesis of 
Campylobacter-induced reproductive disease, IP inoculation resulted in more consistent 
fetoplacental infection with accompanying gross and histologic lesions.  Similar to 
findings in guinea pigs, there was high correlation with fetoplacental infection and gross 
and histological lesions in C. jejuni IA3902 infected murine reproductive tissue. 
The organism was identified via immunohistochemistry for the major outer 
membrane protein (MOMP) within the cytoplasm of trophoblasts and infected 
neutrophils located in necrotic foci at the periphery of the fetoplacental unit, in the 
uterine lumen and the endometrial submucosal tissue including the vasculature, and 
within giant trophoblasts at the periphery of infected the fetoplacental units. 
Extracellularly, C. jejuni was located in and around necrotic foci at the periphery of 
fetoplacental units and within the vasculature of the most severely affected fetoplacental 
tissue/placental disc and uterus. This is partly in agreement with cellular investigations of 
C. jejuni which supports a transcellular translocation.5  Similarly, there is agreement with 
findings from pregnant guinea pig studies, where C. jejuni IA3902 was identified within 
the cytoplasm of trophoblasts, within phagocytes, in extracellular spaces surrounding 
trophoblasts in areas of placentitis and necrosis and occasionally surrounding 
uteroplacental arteries.
7
 The presence of C. jejuni within murine trophoblasts and 
vasculature of the fetoplacental unit is also consistent with what has been described in 
sheep where the organism has been detected within trophoblasts and blood vessels of 
infected ovine placenta.
13
 In that same study, Hedstrom proposed trophoblast necrosis 
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with release of the organism to the chorionic villi and vasculature led to subsequent 
vascular dissemination to the fetus. 
There was strong staining for neutral mucin (PAS) in locations of the 
fetoplacental unit where C. jejuni was located but no staining with Alcian blue (acid 
mucin) in these same tissues. Similarly, there was strong staining for L-fucose (lectin) 
and iron (Perls’ iron) in regions where there was heavy colonization by C. jejuni. This 
indicates that the organism has an affinity for areas of the placental discs where there is 
abundant neutral mucin (at the periphery of the placental discs both within the cytoplasm 
of trophoblasts and extracellularly), iron (within vascular sinusoids of placental discs) 
and L-fucose (cytoplasmic and membrane staining of cells and extracellularly at the 
periphery of placental discs). Previous work has found that mucin, iron and L-fucose are 
trophic factors for C. jejuni IA3902 and the findings in this murine study is consistent 
with and supports data from guinea pig studies.
8
 
The two main limitations of this study were the relatively small number of 
pregnant mice used and the slightly variable gestation lengths. Two strains of mice 
challenged by two different routes were evaluated in this study to assess the mouse as a 
model for C. jejuni-induced reproductive disease.  From these results, BALB/c mice may 
be an appropriate murine model for studying the reproductive tract pathology of C. jejuni 
IA3902, as this strain displayed a wider range of gross lesions including fetal resorption 
and dead pups. That being said, CD-1 mice had 70% high microbial recovery from 
infected fetoplacental discs and may be an alternate consideration as a murine model. IP 
and oral inoculation routes remain viable options for future studies as the organism could 
be recovered by microbial culture from the fetoplacental discs and there were statistically 
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significant inflammatory responses in the reproductive tract using these 2 inoculation 
routes in BALB/c and CD-1 mice. A higher inoculum e.g. 1 ml of C. jejuni IA3902 at 10
9
 
CFU/ml is recommended for oral challenge.  
Currently, the most commonly used model to assess the reproductive 
consequences of C. jejuni infection is the guinea pig, where IP inoculation of IA3902 
resulted in fetoplacental infection, abortion, and demonstrable metritis and placentitis in 
100% of challenged animals.
7
 After oral challenge in pregnant guinea pigs, 7/10 placental 
samples had high numbers of C. jejuni, with each animal from which C. jejuni was 
isolated consistently demonstrating metritis and placentitis.
7
 In this study, C. jejuni was 
recovered from the fetoplacental unit following oral inoculation in only 2/7 BALB/c and 
3/8 CD-1 mice, which was relatively low, yet there was 100% recovery of the organism 
from the fetoplacental disc of IP-inoculated animals from both the BALB/c and CD-1 
groups.  Since the outcomes following IP inoculation were similar, this disparity in 
results between guinea pigs and mice following oral inoculation is likely associated with 
either the ability of the organism to colonize the intestine or translocate across the mouse 
intestine leading to bacteremia.  
 There was 95% isolation of C. jejuni from the feces at necropsy in both strains of 
mice following oral or IP challenge, which suggests similar widespread intestinal 
colonization regardless of strain of mouse. Most mice had moderate counts (50-1000 
CFU) of the bacteria in the feces one week after inoculation though BALB/c inoculated 
IP had high counts (>1000 CFU). So although bacteremia in mice following oral 
inoculation has been demonstrated,
30
  the main problem with the murine model using oral 
challenge may lie with establishing sufficient colonization in the gut to facilitate adequate 
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translocation to the bloodstream. Murine intestinal colonization may be improved by 
using germ-free mice, high challenge doses, mice with humanized microbiota or with 
vancomycin pre-treated  mice.
28
 Future studies could also investigate the reproductive 
pathology of C. jejuni IA3902 on Sigirr deficient (-/-) mice. These mice are deficient in 
Single IgG IL1 Related Receptor (SIGIRR) and  have been proposed as a model for C. 
jejuni pathogenesis as they develop significant intestinal inflammation in response to 
colonization by C. jejuni.
27   
The phenomenal rise of C. jejuni IA3902 as the major zoonotic abortifacient 
pathogen in the sheep industry in the United States, combined with its tetracycline 
resistance and lack of an effective currently approved chemotherapeutic agent, or 
consistently effective vaccines makes the agent a significant force to be reckoned with 
and underscores the value of establishing appropriate animal models to facilitate much 
needed research. Results of this initial study indicate that the murine model can be further 
developed to facilitate reproductive studies with C. jejuni.  
 
Conclusion 
The murine model demonstrated significant potential for future study of the 
reproductive pathology of C. jejuni infection. 100% fetoplacental infection was 
established in BALB/c and CD-1 mice following IP challenge. There was a relatively low 
rate (33% of challenged animals) of fetoplacental infection following oral inoculation 
with C. jejuni IA3902. This was the main shortcoming of the murine model investigated 
in this study compared to the rate (70%) of fetoplacental infection following oral 
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inoculation in the guinea pig model.7 Trophic factors for C. jejuni are present in the 
murine fetoplacental unit, including L-fucose, mucin and iron in locations where the 
organism was confirmed by MOMP IHC, which is similar to reports describing these 
same trophic factors in the guinea pig placenta.8 In the placental disc, C. jejuni was 
present within the cytoplasm of trophoblasts and neutrophils in necrotic foci at the 
periphery of infected fetoplacental units and extracellularly, within and adjacent to 
necrotic foci at the periphery of fetoplacental units and within the vasculature of the most 
severely affected fetoplacental tissue/placental disc. In the uterus, C. jejuni was present 
within neutrophils in the uterine lumen and the endometrial submucosal tissue including 
the vasculature and extracellularly within the vasculature of the most severely affected 
uteri. Histologically, placentitis and endometritis were consistently demonstrated in C. 
jejuni infected murine reproductive tissues. C. jejuni causes a locally extensive 
neutrophilic placentitis with intralesional bacterial colonies, supported by high recovery 
(>1000 CFU) of the organism by microbial culture, conclusively meeting the endpoint 
criteria in this study.  
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Table 1. Number of pregnant mice, litter size, crown rump length and number of 
mice producing live young for mice from which there was high microbial recovery 
(TNTC) of C. jejuni IA3902 from the fetoplacental disc.  
 δ Rounded to one decimal place. β Intrauterine and postpartum. 
 
 
 
 
Table 2. Gross reproductive pathology for pregnant BALB/c and CD-1 mice from 
which there was moderate and high recovery (TNTC) of C. jejuni from the 
fetoplacental disc.   
 
Strain and 
route 
Number of mice 
with dead pups 
Number of mice 
with dead fetuses  
Fetal 
resorption  
Placentitis   Number of pregnant mice with 
high recovery of C. jejuni IA 
3902 from the fetoplacental disc 
Inoculated 
mice 
     
BALB/c Oral 
 
0/10 0/10 0/10 1/10 
 
1 
CD-1 Oral 
 
0/10 1/10 ŧ 
 
0/10 0/10 2 
BALB/c IP 
 
2/10 
 
2/10 
 
2/10 
 
1/10 
 
4 
CD-1 IP 
 
0/10 1/10 
 
0/10  2/10 € 
 
7 
Control mice      
BALB/c 0/4 0/4 0/4 0/4 0 
CD-1 0/4 0/4 0/4 0/4 0 
 
ŧ
 Mouse from which there was moderate recovery (50-1000 CFU) of C. jejuni IA3902 by microbial culture of the fetoplacental unit. 
 € One mouse had a bloody vaginal discharge.  
 
 
 
Strain and 
route of 
inoculation 
Number of pregnant mice
 
with 
high recovery of C. jejuni IA 
3902 from the fetoplacental disc 
Ave. number 
of young per 
litter
δ
 
Ave. crown-
rump length 
(cm)
β 
at necropsy 
Number of 
mice with 
live young  
BALB/c 
Oral 
1 6 3 0/1 
CD-1 Oral 2 13.5 1 0/2 
BALB/c IP 4 5.3 2.5 1/4 
CD-1 IP 7 11.3 1.5 0/7 
Control 
mice 
    
BALB/c 0 7.3 3 4/4 
CD-1 0 11.5 1.5 0/4 
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Table 3. Sample source and semiquantitative recovery of C. jejuni IA3902 cultured 
from pregnant BALB/c and CD-1 mice at necropsy. 
 
*values reported represent number of samples with positive culture results/number of samples available. §Results reported represent 
number of samples within that category/number of samples with positive culture results.  
 
 
 
 
 
 
Table 4. Neutrophil scores of the fetoplacental discs with high recovery (TNTC) of 
C. jejuni IA3902 in pregnant BALB/c and CD-1 mice after oral and intraperitoneal 
inoculation.    
 
   βValues reported represent number of samples available for histological assessment/number of samples with high microbial recovery 
 
 
 
 
 
Strain 
and 
route 
Number of samples culture positive* Low recovery (<50 CFU)§ Moderate recovery (50-1000 CFU)§ High recovery (>1000 CFU)§ 
Inoculated 
mice 
Feces Blood Uterus Fetopla
cental 
Disc 
Feces Blood Uterus Fetopla
cental 
Disc 
Feces Blood Uterus Fetopl
acental 
Disc 
Feces Blood Uterus Fetopl
acental 
Disc 
BALB/c 
Oral 
10/1
0 
4/10 2/8 2/7 1/10 3/10 7/8 1/2 7/10 1/10 0/8 0/2 2/10 0/10 1/8 1/2 
CD-1 
Oral 
9/10 3/10 1/5 3/8 2/9 1/3 0/1 0/3 4/9 2/3 1/1 1/3 3/9 0/3 0/1 2/3 
BALB/c 
IP 
10/1
0 
5/10 7/7 10/10 0/10 3/5 0/7 4/10 2/10 2/5 6/7 2/10 8/10 0/5 1/7 4/10 
CD-1 
IP 
9/10 4/10 3/3 10/10 1/9 2/4 2/3 2/10 5/9 2/4 1/3 1/10 3/9 0/4 0/3 7/10 
Control 
Mice 
                
BALB/c 0/4 0/4 0/4 0/4 0 0 0 0 0 0 0 0 0 0 0 0 
CD-1 0/4 0/4 0/4 0/4 0 0 0 0 0 0 0 0 0 0 0 0 
Strain and 
route 
Number of samples with high 
microbial recoveryβ 
Score 1  
(<10 neutrophils) 
Score 2  
(11-25 neutrophils) 
Score 3  
(26-50 neutrophils) 
Score 4  
(>50 neutrophils) 
BALB/c 
Oral 
1/1 0/1 0/1 1/1 0/1 
CD-1 Oral 2/2 0/2 0/2 1/2 1/2 
BALB/c IP 3/4 0/3 1/3 1/3 1/3 
CD-1 IP 7/7 1/7 4/7 0/7 2/7 
Control 
Mice 
     
BALB/c 0 0 0 0 0 
CD-1 0 0 0 0 0 
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Table 5. Lectin histochemistry and special stains of murine reproductive tissue 
a
 
 
 Subjective Quantification of Staining 
Tissue Type Neutral mucin Acid mucin Iron
b
 LTA
c
 
Periphery of the 
placental disc 
++ - - + 
Parenchyma of 
the placental disc 
+ - + - 
Yolk sac ++ - - + 
Uterine wall - - - ++ 
  a
 Values reported represent the average of all evaluated placental material 
  LTA, Lotus tetragonolobus lectin agglutinin  
  a Scores represent the average of all evaluated tissue from 12 mice: -, low/absent;+, moderate; ++, abundant 
  b Multifocal staining 
  c Membrane staining 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 1-2. Gross reproductive lesions in mice infected with C. jejuni IA3902. Figure 
1. Two mid-term dead fetuses and placentitis. Figure 2. Two resorbed fetuses (placental 
discs without macroscopic evidence of subjacent fetuses).  
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Figure 3-6. Placental discs, mouse. Figure 3. PAS stain with moderate to abundant 
staining at the periphery of an infected placental disc, staining is within the cytoplasm of 
trophoblasts (intracellularly) and extracellularly. Figure 4. Perls’ stain (blue colour) 
multifocally within the parenchyma of the placental disc, mainly within vascular 
sinusoids. Figure 5. Lectin histochemistry for LTA, with moderate to abundant 
multifocal, cytoplasmic and membrane staining of cells of the yolk sac and extracellular 
staining at the periphery of an infected placental disc. Figure 6. Placental disc stained for 
the membrane outer protein of C. jejuni (MOMP). Vascular sinusoids of the placental 
disc are extensively stained red-brown (large numbers of bacteria). 
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CAMPYLOBACTER JEJUNI IA3902 INFECTED MICE 
 
Modified from a paper to be submitted to the Journal of Veterinary Diagnostic 
Investigation 
 
 
 
Victoria D. Lashley
1
, Michael J. Yaeger
1
, Tracy Lindquist
1
 and Ju Ji
2 
 
Departments of 
1
Veterinary Pathology and 
2
Statistics, Iowa State University, Ames, 
Iowa, USA 
 
 
Abstract 
Objective: To investigate the presence of cytokines in the uterus and 
fetoplacental unit of mice infected with C. jejuni IA3902  
Animals: 48 pregnant BALB/c and CD-1 mice   
Procedures: Mice were bred, bled, challenged intraperitoneally and orally, 
euthanized one week post inoculation, necropsied and blood and tissues collected. 
Cytokine levels were quantified in the serum from mice with C. jejuni IA3902 (>1000 
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CFU) cultured from the fetoplacental disc with gross and histological evidence of 
placentitis. Control mice were culture negative with no evidence of gross or histological 
pathology. In situ cellular cytokine production and distribution was assessed in infected 
and control tissues. 
Results: Interleukin 1 beta (IL1β), interleukin 10 (IL 10), interleukin 17A 
(IL17A), tumor necrosis factor alpha (TNF α) and interferon gamma (IFN γ) are 
expressed by specific cells from C. jejuni IA3902 infected fetoplacental tissue. There was 
a statistically significant increase in IL1β, IL6, IL10, IL17A, TNF α and IFN γ in 
maternal serum post infection. 
Conclusions and Clinical Relevance: This is the first report of maternal serum 
cytokine responses in C. jejuni IA3902 infected mice combined with in situ analysis of 
these cytokines. Levels of IL10, an anti-inflammatory cytokine and pro-inflammatory 
cytokines including IL1 β, IL17A, IFN γ and TNF α are elevated during infection with  
C. jejuni IA3902. More research is needed to determine the exact role of these cytokines 
in the reproductive pathophysiology of C. jejuni and to investigate the possibility of 
cytokine immunomodulation as a future therapeutic approach in the management of  
C. jejuni abortion.    
 
Abbreviation 
MH Mueller-Hinton 
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Introduction 
Campylobacteriosis, currently caused primarily by C. jejuni, has been reported as 
the primary cause of infectious abortion in domestic sheep flocks, yet the pathogenic 
mechanisms and virulence factors involved in C. jejuni infections of the reproductive 
tract remain poorly understood.
35
 To investigate disease pathogenesis, evaluate disease 
progression and assess therapeutic strategies, it is imperative that the molecular 
mechanisms of the disease are understood.  
Cytokines are small proteins that regulate cells by binding to receptors present on 
target cells.
42
 Receptor binding triggers intracellular signaling, altered gene expression, 
and the production of other cytokines, surface receptors or feedback inhibition.
23
 
Cytokines function at both the local and systemic levels and can be classified as 
chemokines, lymphokines, or interleukins based on target action, cell of secretion or 
function.
29
 It has been proposed that cells in close proximity functioning as a unit interact 
and respond to stimuli by way of cytokine signals that pass between them.
27
 These 
signals may be amplified, attenuated or provide the stimulus for secretion of other 
mediators, especially when there is inflammation within the affected organ or tissue.
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The analysis of cytokine profiles and their alterations can be very useful to 
investigate host-pathogen interactions, bacterial persistence and bacterial clearance from 
infected hosts.
20
 Additionally, distinct inflammatory profiles (increased IL1 receptor 
antagonist and decreased IL10) at the maternal-fetal interface in humans were mirrored 
by changes in the maternal circulation and may act as biomarkers of placentitis.
18
 
Type 1 cytokines e.g. IFN γ are involved with cellular immune responses and are 
thought to be harmful for pregnancy, for example IFN γ enhances TNF α driven 
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apoptosis of human trophoblast cells.
41
 In addition, these two cytokines activate 
prothrombinase, which initiates the blood clotting mechanism and the subsequent 
production of IL8 which causes endothelial cells and leukocytes to ultimately reduce the 
blood supply to the developing placenta.
45   
 
Type 2 cytokines like IL10, favor antibody responses, inhibit secretion of 
inflammatory cytokines, stimulate trophoblast outgrowth and invasion 
19
 and overall 
favor the maintenance of gestation.
31
 Placental cytokines like IL6, TNF α and TGF β, 
have been reported to play roles in trophoblast cell death (either necrotic or aponecrotic) 
by influencing the activities of caspases and endothelial cell activation. 
12
 IL6, IL1 and 
TNF α are thought to play major roles in early pregnancy and are also elevated in 
inflammatory states. 
37
 TNF α increases with pregnancy and the primary source of its 
production appears to be the placenta, specifically trophoblast cells. IL1β and TGF β may 
cause the destruction of intercellular tight junctions between trophoblasts and endothelial 
cells in placental tissues and facilitate placentitis.
43
 
Cytokines are produced by cells infected with C. jejuni when, lipoprotein JlpA, a 
C. jejuni surface protein, binds to host cell heat shock protein, Hsp90, activating nuclear 
factor kappa-light-chain-enhancer of activated B cells (NFκB) via mitogen-activated 
protein kinases, extracellular signal-regulated kinases (ERK) and p38 mitogen-activated 
protein kinases (MAPK) intracellularly.
44,48
 This cascade is part of the innate immune 
response to microbial pathogens which stimulate the transcription of cytokine genes in 
the C. jejuni infected cell.
11
  
C. jejuni is thought to also be capable of activating NFκB via receptors and 
pathways independent of transmembrane Toll-like receptors (TLRs) and intracellular 
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receptors nucleotide-binding oligomerization proteins (Nods), but these pathways have 
not yet been fully characterized.
4
 Dendritic cells (antigen presenting cells) infected with 
Campylobacter produce NFκB in addition to IL1β, IL6, IL8, and TNF α which triggered 
an innate inflammatory response with an initiated Th1-polarized adaptive immune 
response via IL12, along with increased production of IL10 and IFN γ.22, 21 
In an investigation into the cytokine and chemokine profiles of the placenta on the 
outcome of pregnancy in women exposed to Plasmodium falciparum (P. falciparum), it 
was found that higher placental plasma IL10 levels were associated with P. falciparum 
infections and that IL10 could be a useful diagnostic marker of this infection during 
pregnancy.
13
 Sheep infected with C. jejuni SA with positive identification of bacterial 
antigens in trophoblasts were found to have increased expression of cytokine genes 
involved in pro-inflammatory responses and necrosis.
36
    
RNAscope
®
 technology, which uses in situ hybridization methodologies, provides 
evidence for the cell type, spatial, regional, and possibly temporal specificity of 
expression of cytokines in the placental disc. RNAscope
®
 in situ hybridization allows for 
highly sensitive and highly specific detection of cytokine markers within formalin fixed 
paraffin embedded sections of mice reproductive tissues. This technology amplifies 
signal detection post probe binding while simultaneously suppressing background 
staining and eliminating cross hybridization to unintended targets by the use of unique 
double Z probes that can distinguish RNA sequences with up to 85% homology.
47
  Based 
on these unique advantages, this technique was selected to assess cytokine expression in 
C. jejuni infected, murine fetoplacental tissue.   
59 
 
The purpose of this study was to enhance our understanding of the pathogenesis 
of reproductive disease caused by C. jejuni by investigating changes in maternal serum 
cytokine expression in pregnant mice infected with this abortifacient strain (IA3902) and 
utilizing in situ hybridization technology to assess cytokine expression following 
infection of the fetoplacental unit.   
 
Materials and Methods 
30 BALB/c mice (24 females and 6 males) and 30 CD-1 mice (24 females and 6 
males), 6-8 weeks old were sourced from a commercial supplier 
a
 and acclimated for 5 
days. Four female mice were group housed with one male mouse for 14 days. On day 15, 
females were bled and inoculated either with 0.1 ml intraperitoneally (IP) or 0.5 ml orally 
(O) 1x10
9
 colony forming units (CFU) /ml of C. jejuni IA3902. Blood was collected (0.1-
0.2 mls of blood) via the lateral saphenous vein using a 25 G needle. Mice were 
restrained in 50 ml open ended conical tubes which allowed for the animal’s rear leg to 
be held through the open end of the tube, hair was shaved using a small electric clipper, 
petroleum jelly was lightly rubbed onto the skin to help the vein standout, the vein was 
gently pricked with the needle and blood collected by capillary action into a hematocrit 
tube. After collection a sterile gauze pad was gently pressed over the puncture site to stop 
bleeding. Blood was allowed to clot in 1ml Eppendorf tubes
b
, centrifuged at 3000g for 15 
mins, serum extracted and re-centrifuged at 10, 000g for 10 mins and stored at -80 
0
C 
until tested. Oral inoculation took place after a 12 hour long feed withdrawal on ten 
female mice from each mouse strain. Mice were lightly anesthetized via gas anesthesia in 
an anesthetic chamber with 2 % isoflurane and then inoculated orally with 0.5 mls of C. 
60 
 
jejuni IA3902 at 10
9
 CFU/ml, via gastric lavage using a stainless steel, ball-tipped 24 
gauge 1.0 inch animal feeding tube. Ten female mice of each strain were inoculated IP. 
Each mouse was briefly placed on its back with its head tilted slightly downward and 0.1 
ml of C. jejuni IA3902 at 10
9
 CFU/ml injected IP using a 25G needle.   
After inoculation female mice were immediately removed and housed in 
individually identifiable cages for observation twice daily for one week for clinical signs 
of inactivity, unresponsiveness, ruffled hair coat, diarrhea, vaginal discharge and abortion 
(fetal loss). All mice were humanely euthanized one week post inoculation. For 
euthanasia, mice were rendered completely unconscious using 100-200 µl IP 
Ketamine/Xylazine (80/16 mg/kg).  Cardiac blood was collected for serum preparation 
and storage as described above. This was followed by exsanguination, in accordance with 
AVMA Guidelines for Euthanasia of Animals, 2013 edition.  
 
Necropsy, microbial culture and histopathology 
All mice were subjected to a complete necropsy. At necropsy, all gross lesions 
were noted and samples collected for microbial culture and histological examination. 
Cecal swabs were obtained using sterile minitip cotton swabs
c
 immediately after 
euthanasia. Uterus, placenta and fetal tissue were harvested in sterile petri dishes for 
Campylobacter culture. All samples for microbial culture were refrigerated immediately 
upon collection and plated on the day of collection. Cecal swabs and blood were directly 
streaked onto culture media. Uterus and fetoplacental tissue were minced, swabbed and 
streaked onto MH agar containing a Campylobacter selective supplement 
d
 (polymyxin 
B, rifampicin, trimethoprim and cycloheximide) and a Campylobacter growth 
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supplement 
e 
(sodium pyruvate, sodium metabisulfite and ferrous sulfate). Plates were 
incubated for 48 hours in anaerobic jars under micro aerobic conditions at 42 
o
C. 
Campylobacter colonies were counted on each plate to determine the number of CFU in 
each sample. 
Uterus, fetoplacental unit, placenta, maternal liver and gallbladder were examined 
histologically. Tissues were fixed in 10% neutral buffered formalin for 24 hours. 
Preserved tissues were paraffin embedded and 5-7 micron diameter sections were 
mounted on slides and routinely stained with hematoxylin and eosin.  
The study was approved by Institutional Animal Care and Use (IACUC), protocol 
5-15-8018-M at Iowa State University and fully compliant with the regulations of the 
Laboratory Animal Resources (LAR) group at whose facility the study was undertaken.  
Appropriate personal protective equipment was worn in the animal treatment and 
necropsy rooms.  
Serum cytokine testing: The Bio-Plex Pro
TM
 6 Plex (IL1β, IL6, IL10, IL17A, 
TNF α and IFN γ) Mouse Cytokine Assay f was used to detect cytokines in serum. This 
assay was able to quantify the levels of six serum cytokines using magnetic beads. The 
Bio-Plex® 200 reader g used a red (635 nm) laser that illuminated the fluorescent dyes 
within each bead to provide bead classification and identification and a green (532 nm) 
laser that excited the photoelectrons to generate a reporter signal, which was detected by 
a photomultiplier tube (PMT). A high-speed digital processor managed the data output 
and produced median fluorescence intensity (MFI) values as well as concentration in 
picograms per milliliter (pg/ml). The concentration of analyte bound to each bead was 
proportional to the MFI of the reporter signal. Prior to serum testing, the Bio-Plex® 200 
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system was warmed up, calibrated, a wash station prepared and all cytokine standards 
were reconstituted and diluted according to manufacturer’s instructions. A 96 well plate 
was used, which after allowing for cytokine standards and duplicate testing of all samples 
and standards permitted 4 mouse samples to be tested per group (4 per oral CD-1, IP CD-
1, oral BALB/c and IP BALB/c) before challenge and these same 4 mice per group had 
serum tested post challenge (from necropsy) along with 2 control serum samples per 
strain (2 BALB/c and 2 CD-1) before challenge and 3 control serum samples from these 
same mice post challenge. Stored sera from mice that had microbiological, gross or 
histological evidence of C. jejuni IA3902 infection were used.   
Selected mouse serum samples were removed from -80 
o
C, thawed and kept 
refrigerated until tested. Dilutions were prepared just prior to the start of the assay and 
equilibrated to room temperature before use. Coupled beads were prepared 1X 
concentration from 20X stock and included 20% excess volume. The Bio-Plex Pro
TM
 6 
Plex (IL1β, IL6, IL10, IL17A, TNF α and IFN γ) Mouse Cytokine Assay was run after all 
reagents and samples were brought to room temperature. 50 µl of beads were added to 
wells, wells were then washed twice using 100ul wash buffer.  50 µl standards, blanks, 
and samples were added to wells and incubated at room temperature on a shaker set to 
850 rpm. Wells were washed three times with 100 µl wash buffer, 25 µl of detection 
antibody was added to the wells and the plate incubated on a shaker at 850 rpm for 30 
min.  Wells were washed three times with 100 µl wash buffer, 50 µl of streptavidin-PE 
was added and the plate incubated 850 rpm for 10 mins at room temperature, washed 
three times with 100 µl of wash buffer and resuspended in 125 µl assay buffer for 30 sec 
at 850 rpm. The plate was then read on the Bio-Plex 200 system reader. 
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In order to determine tissue cytokine levels and distribution, the RNAscope
®
 
Assay
h  
was used. Sections were selected from the 4 infected study groups (oral CD-1, IP 
CD-1, oral BALB/c and IP BALB/c) along with 2 uninfected control mice that had serum 
cytokine levels evaluated. Three slides each from oral CD-1, IP CD-1, IP BALB/c and 2 
slides from oral BALB/c were used. Each cytokine probe was also tested on control 
slides from uninfected mice.  The C. jejuni IA3902 probe was tested on 4 slides based on 
histopathological evaluation along with one control (uninfected mouse) and negative and 
positive assay probes.  Slides were prepared by cutting paraffin embedded blocks into 5 
microns sections and mounted on Superfrost Plus slides. Slides were then baked for 1 
hour, deparaffinized for 20 minutes, and pretreated by applying Pretreat 1 for 10 mins, 
Pretreat 2 for 30 mins, a hydrophobic barrier was created around the tissues on the slides 
then Pretreat 3 was applied for 1 hour. The RNAscope
®
 2.0 HD Detection Kit (Brown) 
was used. The RNA-specific cytokine probes 
i
 were: - Probe - Mm-Il17a; Probe - Mm-
Il10; Probe - Mm-Il6; Probe - Mm-Il1b; Probe - Mm-Ifng and Probe - Mm-Tnfrsf1a. The 
C. jejuni IA3902 was custom designed based on the sequence, 
RS: NC_017279 (GB: CP001876). All probes were applied for 2 hours to allow 
hybridization. Signal was amplified using multiple steps - Amplification reagent (Amp) 1 
was applied for 30 mins, Amp 2 for 15 mins, Amp 3 for 30 mins, Amp 4 for 15 mins, 
Amp 5 for 30 mins and Amp 6 for 15 mins. The amplified signal (target RNA) was 
detected using Diaminobenzidine (DAB) substrate; slides were counterstained, 
dehydrated and coverslips were mounted. Tissue sections were examined under an 
Olympus BX 41standard bright field light microscope at 20-40 X magnification. The 
assay allowed for a semi-quantitative scoring based on the number of punctate dots 
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present within each cell boundary. Assessment of staining was based on the protocol 
designed by the company and was categorized into five grades (with criteria in 
brackets):- 0 (no staining or less than 1 dot per 10 cells), 1 (1 to 2 dots per cell), 2 (4-9 
dots per cell, none or very few dot clusters), 3 (10-15 dots per cell and < 10% dots in 
clusters) and 4 (>15 dots per cell and >10% dots are in clusters) (Figure 1). 
 
Statistical Analysis 
The analysis was done in SAS 
j
 with the proc mixed procedure with mice as the 
random block effect, cytokine levels as the response, and infection, mouse strain and 
route as the three fixed effects. Results were considered significant at values of p ≤ 0.05. 
 
Results 
Serum was evaluated from 9 mice from which high numbers of C. jejuni IA3902 
(>1000 CFU) was cultured from the fetoplacental disc and uterus, and from six control 
mice from which the organism was not recovered. The 9 mice from which C. jejuni was 
isolated had gross evidence of placentitis (edematous and hemorrhagic, yellow or green 
placental discs), fetal resorption (placental disc without macroscopic evidence of a 
subjacent fetus, intrauterine fetal death (tan/white mid-sized conceptus) and term dead 
pups (stillborn pups). In these mice there was histological evidence of increased numbers 
of neutrophils within the periphery of the placental disc and within the uterine wall. 
Additionally, the presence of C. jejuni IA3902 was confirmed within affected 
fetoplacental discs with strong positive cytoplasmic in situ RNA hybridization staining in 
neutrophils and trophoblasts as well as extracellularly within areas of placentitis (Figure 1 
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A and B). Control mice were culture negative and had no evidence of gross pathology. 
Control mice that had given birth, had low to moderate numbers of neutrophils within the 
uterine wall, an expected postpartum finding (Table 1). 
The output done in SAS with the proc mixed procedure with mice as the random 
block effect, cytokine levels as the response, and infection, mouse strain and route as the 
three fixed effects indicated that there was a significant difference in the levels of 
cytokines for mice before and after infection with C. jejuni IA3902. Mice with infection 
tended to have higher cytokine levels. This result held for IL1β with an increase of 
216.75 pg/ml and p value 0.0038; IL-10 with an increase of 134 pg/ml and p value 
0.0021; IL-17A with an increase of 347.65 pg/ml and p value 0.0201; IFN γ with an 
increase of 75.84 pg/ml and p value 0.0063) and TNF α with an increase of 1384.69 
pg/ml and p value 0.0042. However, there was no significant difference in cytokine levels 
between the BALB/c and CD-1 strains of mice, and there was no significant difference 
between the intraperitoneal route and oral route of administration. In addition, there was 
no significant interaction among the three fixed effects. 
IL6 was not present in detectable levels via the Bio-Plex
®
 200 serum cytokine assay 
either before or after inoculation in any mouse in the study. 
 
RNAscope
®
 Results 
In C. jejuni IA3902 infected reproductive tracts IL1β originated primarily from 
the endometrial mucosa and non-degenerate neutrophils within the placenta, especially at 
the periphery of the placental disc (Figure 1 C). The staining intensity in neutrophils 
within these areas had a score of 4. IL10 was produced from trophoblasts and 
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endometrial mucosal cells with a score of 3. IL17A was produced by placental 
trophoblasts and endometrial mucosal cells with a score of 1. TNF α was produced in 
trophoblasts (score of 4) (Figure 1 D), endometrial mucosal cells (score of 4), stromal 
cells of the myometrium (score of 4) and cells of the yolk sac (score of 3). IFN γ was 
produced from trophoblasts and endometrial mucosal cells with a score of 2. Control 
slides had a score of 0 (no staining or less than 1 dot per 10 cells) for IL10, IL17A, and 
IFN γ. Control slides for TNF α had a score of 1 (1 to 2 dots per cell) for trophoblasts, 
endometrial mucosal cells, stromal cells of the myometrium and cells of the yolk sac. 
Control slides had a score of 1for IL1β which originated from neutrophils, located within 
the vasculature of the placenta and endometrium (Table 2). IL6 did not have significant 
detectable cellular RNA in either inoculated mice or control mice.  
 
Discussion 
In this study, high levels of IL1β mRNA were expressed in non-degenerate 
neutrophils within the placenta, endometrial mucosa and endometrial lumen. IL1β is a 
central mediator of innate immunity and inflammation and is expressed and/ or affected 
by all cells of the innate immune system.
17
  Its main function is to control pro-
inflammatory reactions in response to tissue injury by pathogen-associated-molecular 
patterns (PAMPs, such as bacterial products) or damage- (danger-) associated molecular 
patterns (DAMPs) released from damaged cells.
49
   
IL1β has been detected in placental tissue and is implicated as an endogenous 
mediator of inflammation and parturition.
30
  In chorioamnionitis, IL1β immunoreactivity 
was noted in trophoblasts, vascular smooth muscle, stromal cells and decidua.
7
  IL1β was 
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found to act as a mediator of endothelial cell function and the placenta contributed to 
elevation in serum levels within the maternal circulation.
5
 While the placenta was thought 
to produce small quantities of IL1β, trophoblasts can be induced to produce significant 
quantities of bioactive IL1β in vitro via endotoxin stimulation as evidenced by increased 
m RNA expression.
25
  
High levels of IL10 mRNA were expressed in trophoblasts with lesser quantities 
from the endometrial mucosa. IL10 is an anti-inflammatory cytokine that inhibits the pro-
inflammatory activity of immune cells like Th1, NK cells and macrophages, all of which 
are required for optimal pathogen clearance and more than any other cytokine, is an 
essential part of the immune regulatory response in almost all infections.
14
 IL10 is 
proposed to be the key cytokine for the maintenance of pregnancy and inhibits the 
secretion of inflammatory cytokines such as TNF α in rats where it was found that 
declining IL10 plasma levels were related to embryonic compromise and that it can be 
used a predictor of embryo-fetal and placental pathology in diabetic rats.
39
  
Small amounts of IL17A mRNA were produced by placental trophoblasts and 
endometrial cells. While there are six members in the IL17 cytokine family, biological 
function of IL17A and IL17F are the best understood and mediate pro-inflammatory 
responses.
24
 When pathogens invade mucosal tissues, IL17 induces the production of 
antimicrobial proteins such as beta-defensin 2, antimicrobial proteins, lipocalins and 
calgranulins, CXC chemokines and granulocyte colony-stimulating factor which results 
in protection from bacterial infection.  In human recurrent pregnancy loss, high levels of 
IL17, IL6 and IL1β have been reported.16  
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IFN γ was produced from trophoblasts and endometrial mucosal cells at moderate 
levels. This is in agreement with other reports from mouse studies.32,50 It is a type II 
interferon and the coordinator of a wide array of cellular processes because of its ability 
to regulate the transcription of immunologically relevant genes.
10
 It is the sole type II 
interferon and its production is controlled by cytokines secreted by antigen presenting 
cells (APCs), mostly IL12 and IL18.
38
 Negative regulators of IFN γ production include 
IL4, IL10, transforming growth factor beta and glucocorticoids.
15
 Pathogen products like 
lipopolysaccharide (LPS) augment local IFN γ production of this pro-inflammatory 
cytokine, which in turn amplifies the immune response to these agonists.
40
  
IFN γ also has the ability to synergize or antagonize the effects of cytokines, 
growth factors and pathogen associated molecular patterns (PAMPs) signaling pathways 
(e.g. TNF α, IL4, IFN alpha/beta, LPS).38 It is interesting that elevation in IFN γ has been 
associated with mid gestation fetal loss in mice,
28
  which is in agreement with our 
findings in this study. Similarly, an increase in IFN γ production was reported to induce 
abortion in a mouse model of B. abortus infection.
26
 
In this study, high levels of TNF α mRNA as detected by RNAscope® were 
present in trophoblasts, endometrial mucosa, stromal cells of the myometrium and cells 
of the yolk sac. While macrophages are believed to be the main source of TNF α, it is 
also produced by a wide variety of other cells including endothelial cells, fibroblasts and 
neuronal tissue and its release is triggered by bacterial products and lipopolysaccharides.
6
  
TNF α is thought of as a major pro-inflammatory mediator, with strong 
immunostimulatory activities, is able to induce apoptosis and engage in tissue 
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regeneration/expansion and destruction and is capable of a wide spectrum of biological 
activity to which most cells are responsive.
46
  
IL6 is a pro-inflammatory cytokine with roles in Th 2 responses and antibody 
production. 
9
 While IL6 can be found within the reproductive tract,
33
 it did not appear to 
have a major role in the pathology of abortifacient C. jejuni IA3902 in BALB/c and CD-1 
mice used in this study. This is in contrast to other work, which suggested roles for IL6 in 
the immunity and pathogenesis of Campylobacter; specifically that it enhanced local 
enteric and systemic antibodies to C. jejuni.
8
 Similar to findings in our study, Abram, 
2000, found that C. jejuni did not promote the induction of IL6 systemically when 
C57BL/6 mice were infected by the intraperitoneal route.
1
 The strain of mouse may play 
a role in cytokine production as IL6 was found to be associated with murine abortion in 
CBA/J x BALB/c and CBA/J x DBA/2J mating combinations.
51
 
The findings in this study were in agreement with reports by Al-Banna et al, 
2012, in which there was the production of both pro-inflammatory and anti-inflammatory 
cytokines in the small and large intestine after infection with C. jejuni in mice.
3
 There is 
also agreement with other studies on human epithelial INT-407 cells found that C. jejuni 
induced high mRNA expression of pro-inflammatory cytokines IL1β, IFN γ and TNF α 
and anti-inflammatory cytokines IL10.
2
 By analyzing experimental data using structural 
equation models (SEM) in birds, it was also found that there was primarily a T helper 
(Th) 17 response (IL17A, IL17F, IL22) in broiler chickens after C. jejuni infection that 
limited the invasion of the bacteria into the caeca.
34
  
Studies on cytokines, more specifically cytokines in gestation can be complicated 
and many times elucidate results that may conflict with other studies. This is likely based 
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on the use of different methods of testing and analysis in different animal models and the 
fact that there are individual variations coupled with the often dual roles performed by 
most cytokines. The cytokine serum assay using the Bio-Plex ProTM Mouse Cytokine 
Assay demonstrated that both pro-inflammatory (IL 1, IL 17, IFN γ and TNF α) as well as 
anti-inflammatory cytokines (IL 10) play a role in the reproductive pathology of  
C. jejuni IA3902 infected BALB/c and CD-1 mice and that maternal serum levels reflect 
placental cytokine alterations. The number of fetuses, stage of gestation, dose of 
inoculum used and time of infection may influence the type and amount of placental 
cytokines produced.  
The use of the in situ RNAscope
® 
technology provided visible support that the 
source of serum cytokines was the placenta and uterus in infected animals as control mice 
did not produce detectable IL10, IL17 and IFN γ and IL1 and TNF α was only produced 
at very low levels. Mice with high recovery of C. jejuni IA3902 (>1000 CFU) had 
cytokine scores above 2 for IL1 β, IL10, IL17 A, IFN γ and TNF α as assessed by the 
RNAscope
® methodology. IL6 did not have significant detectable cellular mRNA in 
either inoculated mice or control mice; neither was a serum cytokine level detectable by 
the Bio-Plex® 200 cytokine assay before or after inoculation with C. jejuni IA3902. 
With the use of RNAscope® technology, there was the additional benefit of being 
able to identify the cell types that were involved in producing the placental cytokines and 
their spatial distribution within the reproductive tissue. Also, it was possible to semi 
quantify or score placental cytokine production. Based on these results, while there 
appears to be an anti-inflammatory response as reflected in an IL10 score of 3, as 
expected there was an overriding pro-inflammatory response with IL17 and IFN γ scores 
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of 2 and IL1β and TNF α scores of 4. This supports and emphasizes the role of the 
reproductive tract and uterus as the main source of circulating cytokines in these mice.  
 
Conclusion 
This is the first study to report on the maternal serum cytokine responses in  
C. jejuni IA3902 infected BALB/c and CD-1 mice combined with in situ analysis of 
these cytokines within the murine reproductive tract. This work strongly suggests that (1) 
IL1β, IL10, IL17A, TNF α and IFN γ are involved in the pathogenic mechanisms of the 
reproductive tract infection of C. jejuni IA3902, (2) that these cytokines can be measured 
in the maternal serum and in situ production can be demonstrated within fetoplacental 
and uterine tissue after infection with the organism and (3) that trophoblasts within the 
placental disc are primary source of these cytokines while endometrial mucosal cells, 
endometrial stromal cells, cells of the yolk sac and neutrophils also produce significant 
amounts of cytokines when the pregnant murine uterus is infected with C. jejuni IA3902. 
Levels of IL10, an anti-inflammatory cytokine and pro-inflammatory cytokines including 
IL1 β, IL17A, IFN γ and TNF α are elevated during infection with C. jejuni IA3902. IL6 
was not detectable either in maternal serum or within cells of the placenta and thus may 
not appear to play a significant role in the reproductive pathology of C. jejuni IA3902 in 
BALB/c and CD-1 mice. This study has identified a number of cytokines modulating 
placental infection with C. jejuni IA3902. Further research is needed to determine the 
role of these cytokines in the pathogenesis of C. jejuni abortion and the possibility of 
cytokine immunomodulation as a future therapeutic approach due to the high prevalence 
of antibiotic resistance with this pathogen.    
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Footnotes 
a. Charles River, Wilmington, MA. 
b. Fisher Scientific, Pittsburgh, PA. 
c. BBL CultureSwab, Becton-Dickinson Co, Franklin Lakes, NJ. 
d. Preston Campylobacter selective supplement, Oxoid Ltd, Cambridge, England 
e. Campylobacter growth supplement, Oxoid Ltd, Caambridge, England 
f, g. BIO RAD, California, USA 
h, i. Advanced Cell Diagnostics, Inc. (ACD) USA  
j. SAS, version 9.4, SAS Institute Inc., Cary, NC 
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Table 1. Summary of infection for BALB/c and CD-1 pregnant mice used for serum 
cytokine testing following oral and IP inoculation with C. jejuni IA3902 based on 
microbial culture, gross pathology and histopathology. 
 
Strain and route 
of inoculation 
Microbial culture positive* 
>1000CFU (uterus and/or placenta) 
Gross pathology 
Histopathology 
(neutrophil score) § 
Inoculated Mice   Periphery of placenta Uterine wall 
BALB/c Oral 2/4 Placentitis +++ 
++++ 
+++ 
CD-1 Oral 1/3 Dead fetus ++++ +++ 
BALB/c IP 3/4 
Fetal resorbtion 
Dead fetuses 
Dead pups 
+++ 
++++ 
++ 
+++ 
++ 
+++ 
CD-1 IP 4/4 
Placentitis 
Dead fetuses 
 
++ 
++ 
++++ 
+ 
 
+++ 
+++ 
++ 
+ 
Control Mice     
BALB/c 0/2 Absent 0 ++ 
CD-1 0/2 Absent 0 + 
*values reported represent number of samples with positive culture results/number of samples tested. §Neutrophil count in five  
40X fields, scored as follows: +=<10 neutrophils, ++=11-25 neutrophils, +++=26-50 neutrophils, ++++=>50 neutrophils  
 
 
Table 2. Summary of semiquantitative RNAscope
®
 scores for cytokines evaluated 
within placental and uterine cells in inoculated and control mice. 
-= Score of 0; += Score of 1; ++=Score of 2; +++=Score of 3; ++++=Score of 4 
 
 Inoculated mice Control mice 
Cytokine Tropho
blast 
Endome
trial 
mucosal 
cells 
Endome
trial 
stromal 
cells 
Yolk 
Sac 
cells 
Neutrophils in 
placenta, 
endometrial 
mucosa and 
endometrial 
lumen 
Trophob
last 
Endometrial 
mucosal 
cells 
Endometrial 
stromal 
cells 
Yolk Sac 
cells 
Neutrophils in 
placenta and 
endometrium 
IFN γ ++ ++ - - - - - - - - 
IL17 ++ ++ - - - - - - - - 
IL10 +++ +++ - - - - - - - - 
TNF α ++++ ++++ ++++ ++++ - + + + + - 
IL1β - - - - ++++ - - - - + 
IL6 - - - - - - - - - - 
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Figure 1. Photomicrographs of RNAscope sections of murine placental discs infected 
with C. jejuni IA3902, probed and stained for cytokines and C. jejuni IA3902. (A) C. 
jejuni staining at the junction of the placental disc and endometrium, there is strong 
positive red-brown staining within neutrophils and extracellularly. (B) C. jejuni Positive 
staining multifocally within trophoblasts, which are occasionally distended quite 
markedly. (C) IL1β staining within the cytoplasm of neutrophils, score 4 (>15 dots per 
cell and >10% dots are in clusters) at the periphery of an infected placental disc. (D) 
Staining of TNF α within trophoblasts, score 4, in an infected placental disc.  
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Abstract 
Objective: To develop a model of ovine abortion and discuss the experimental 
findings and challenges encountered during this attempt. Two studies were conducted, in 
which pregnant sheep were inoculated with a highly pathogenic, abortion inducing clone, 
Campylobacter jejuni (SA clone), isolated from a sheep abortion using various routes and 
doses.   
Procedures: Primiparous ewes were administered C. jejuni IA3902 (a clone SA 
isolate) via the oral route, intraperitoneal (IP) route or intravenous (IV) route at 
approximately 100 days gestation. Animals that aborted or showed significant evidence 
of impending disease were immediately euthanized and necropsied. Remaining ewes 
were euthanized at the termination of the study 21 days post inoculation (DPI). Samples 
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were collected for microbial culture, histologic examination and immunohistochemical 
analysis. 
Results: Large doses of C. jejuni IA3902 administered orally and IP failed to 
result in demonstrable fetoplacental infection.  Three sheep inoculated IV aborted and 
three died. C. jejuni was recovered in high numbers from placenta and uterus and in 
moderate numbers from fetal lung and liver of animals inoculated via the IV route. In the 
placentome, there were histological changes of rounded, swollen trophoblasts, cellular 
and nuclear debris, vascular congestion and hemorrhage. Immunohistochemistry (IHC) 
confirmed the presence of the organism within trophoblasts, fetal villi and endometrial 
glands.  
Conclusions and clinical relevance: This is the first report of C. jejuni within 
fetal villi and endometrial glands of infected ovine reproductive tissues. Challenges 
encountered are discussed and suggestions made for future investigations. These include 
measures for mitigating the effects of endotoxin by washing the culture prior to IV 
administration, premedicating ewes with non-steroidal anti-inflammatory drugs as well as 
using confirmed C. jejuni clone SA infected placenta from IV inoculated ewes for future 
oral inoculation studies. 
 
Abbreviation 
MH  Mueller-Hinton 
ABSL 2 Animal Biosafety Level 2 
PBS  Phosphate buffered saline 
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Introduction 
C. jejuni is a major cause of food-borne bacterial gastroenteritis in humans 
worldwide and one of the most important causes of abortion, stillbirth and neonatal death 
in sheep.
22
 Historically, there has been significant antigenic and genetic heterogeneity of 
Campylobacter isolates associated with ovine abortion, 
9
 however within the last decade, 
a single genetic clone as determined by pulsed field gel electrophoresis (PEGE) and 
multilocus sequence typing (MLST) has become the predominant cause of abortion in 
sheep in the United States.
22
 This clone is universally tetracycline resistant and termed C. 
jejuni clone SA (for Sheep Abortion), of which C. jejuni IA3902 represents a clinical 
isolate obtained from a sheep abortion outbreak in Iowa.
22
 C. jejuni abortion is regarded 
as being highly contagious within flocks, with sheep likely getting infected via the oral 
route following exposure to aborted fetal materials including amnion, placenta and 
licking the fetus, uterine discharge or feces.
25
 Abortion rates and infection of up to 70% 
of ewes in naïve flocks have been reported.
19
  
Infected sheep intermittently shed Campylobacter sp. in feces with the highest 
rates of fecal shedding associated with periods of increased ‘stress’ as a result of lambing, 
weaning and flock movement.
26
 C. jejuni clone SA has been identified in raw milk, cattle 
feces, the feces and bile of healthy sheep as well as in aborted material from sheep, cattle 
and goats.
21
 The combined SmaI and KpnI PFGE patterns of clone SA from sheep were 
indistinguishable from those of 123 (9.03%) human C. jejuni isolates (1,361) in the 
Centers for Disease Control (CDC) database, highlighting its zoonotic potential.
21
 
Reports describing the reproductive pathology caused by C. jejuni following 
experimental infection in sheep are limited and findings are sometimes inconsistent. 
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Hedstrom et al, 1987, demonstrated that C. jejuni was abortifacient in sheep after seven 
IV inoculated ewes aborted within 7 and 12 days post infection (DPI).
12
 In another C. 
jejuni/sheep study by Sanad et al,  2014, the same IV dose that Hedstrom used was 
administered to two sheep and one sheep died 20 hours post inoculation while the other 
had a normal delivery 6 weeks post inoculation.
23
 Additionally, there are disparities 
between the results of experimental infection compared to descriptions of field outbreaks. 
For example, there tends to be a low incidence of fetal bronchopneumonia  in 
experimentally inoculated cases whereas this histological lesion is found in the lungs of 
nearly all fetuses from field cases.
12
   
Research in this area is negatively impacted by the high costs associated with 
sourcing and maintaining sufficient numbers of C. jejuni naïve pregnant sheep for 
lengthy research studies. Despite these obstacles, it is important to develop a reliable 
pregnant sheep model to further our understanding of important virulence determinants in 
the host species and to conduct investigations into the development of protective immune 
mechanisms against the organism in the host species. The ultimate goal would be to 
develop on farm prevention strategies and vaccination protocols to limit livestock losses 
as a result of C. jejuni associated abortion.   
Without the ability to reliably reproduce this disease experimentally, many 
important aspects of this disease remain a mystery, including the infectious dose of C. 
jejuni needed to induce disease; the incubation period between oral ingestion and 
abortion and the pathogenesis of abortion, including the precise role that endotoxin may 
play in abortion induction. Additionally, a reliable pregnant sheep model is necessary to 
further our understanding of important virulence determinants and to conduct 
84 
 
investigations into protective immune mechanisms against the organism in the host 
species.   
 
Materials and Methods 
Humane animal care and use—All procedures described herein were approved by 
the Institutional Animal Care and Use Committee (IACUC) at Iowa State University 
(ISU), Ames, IA 50011, protocol IACUC1-12-7407-OP. The C. jejuni IA3902 isolate 
used in our study is a prototypical, clinical isolate of clone SA recovered from an aborted 
sheep placenta in 2006 obtained from the Iowa State University Veterinary Diagnostic 
Laboratory.  IA3902 has been shown to be highly virulent in inducing abortion in 
pregnant guinea pigs.
5
 This tetracycline resistant strain is a representative isolate of the 
predominant clone associated with abortion in sheep as previously determined by PFGE 
and MLST.
22
 
Primiparous crossbred commercial ewes at approximately 100 days of gestation 
(confirmed via ultrasound) were sourced from a local flock and allowed to acclimate for 
3 days upon arrival at the ISU Laboratory Animal Resources (LAR) research facility. 
Pre-inoculation serology testing indicated that these sheep had low levels of C. jejuni 
specific antibodies via ELISA.  A pre-inoculation rectal swab from all ewes was cultured, 
both by a direct fecal smear and fecal enrichment. A single Campylobacter colony was 
isolated from one sheep from the IP group. This was later identified as C. sputorum by 
matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-
TOF MS) and confirmed as a non-clone SA isolate by specific PCR. Ewes were housed 
in individual pens in an ABSL 2 facility and were identified via ear tags and individual 
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cage identification. All ewes were fed Teklad-Envigo 7060
a
 small ruminant complete 
ration with water available ad lib.  
The pilot study used 9 pregnant ewes, divided evenly into 3 groups, one group 
was inoculated orally, another group was inoculated IV and the third group was 
inoculated IP. All groups were inoculated with C. jejuni IA3902 cultures that were 
washed in sterile 1 x PBS to remove free endotoxin from the growth media. This was 
done by harvesting the bacterial culture grown on the agar plate in PBS and followed by 
centrifuging the suspension (at 3,000 x g for 15 min) then re-suspending the pellet in PBS 
again to obtain the desired concentration of inoculum. 20mls of 1x109 colony forming 
units (CFU)/ml C. jejuni IA3902 was inoculated orally into three ewes with a 20 ml oral 
dosing syringe.   
The oral group was fasted for 12 hours prior to inoculation in order to minimize 
rumen fill and to slow gastrointestinal transit time with the aim of improving oral 
infection following oral inoculation. Water was not withheld. IV inoculation was via an 
18G, 2 inch long IV catheter 
b
 temporarily placed in the jugular vein. The three ewes in 
the preliminary study received 1 ml of inoculum containing 1x10
8
 CFU/ml.  For IP 
inoculation, ewes received 1ml of 1x10
8
 CFU/ml, using an 18 G 1inch sterile needle 
c
 and 
ewes were fully conscious and restrained manually. The site of inoculation was localized 
with the use of ultrasound on the right upper quadrant of the flank caudal to the rumen 
and dorsal to the uterus. The inoculation site for both IV and IP administration was 
sheared and aseptically prepared using alternate Chlorhexidine
®, d
 (chlorhexidine 
gluconate 2.0%) and Isopropyl alcohol (70%) swabs 
e
 performed three times.   
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The larger study, conducted 4 months later, in May 2016 utilized 15 pregnant 
ewes divided into 3 groups. One group of 3 ewes was inoculated orally, a group of 6 
ewes was inoculated IV and the final group of 6 ewes was inoculated IP, using C. jejuni 
IA3902 cultures that were unwashed (endotoxin not removed). Oral inoculation was via a 
short orogastric tube placed in the distal esophagus with 50 mls of 2.1x10
10
 CFU/ml C. 
jejuni IA3902 inserted directly into the rumen and flushed with an equal volume of 
culture broth.  Six ewes were inoculated IV with 2-5 mls of 1.5x10
9
 CFU/ml.  Six ewes 
were inoculated IP with 5-6 mls of 5x10
9
 CFU/ml. (Table 1). 
Following inoculation, animals were monitored three times daily for evidence of 
depression, loss of appetite, prolonged recumbency, elevated temperatures, and abortion 
(genital bleeding, expelled fetus). For the oral and IP groups, blood was collected 
aseptically at 4 and 11 days post inoculation (DPI) and at necropsy for microbial culture. 
Blood collection was done using a sterile 18G vacutainer needle and 10 ml red top 
vacutainer tubes to withdraw blood from the jugular vein. Fecal swabs were taken for 
culture at the same time to assess fecal shedding. Ewes that aborted were immediately 
euthanized with euthanasia solution (Beuthanasia
®, f  
sodium pentobarbital 390mg + 
sodium phenytoin 50 mg/ml) at 0.22mg/kg, intravenously using an 18 G needle, as per 
AVMA Guidelines on Euthanasia (AVMA, 2013). The study was concluded 21 days 
post-inoculation and all remaining animals were euthanized at that time and necropsies 
performed.  
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Necropsy and collection of samples 
Necropsy involved inspection for gross lesions and sample collection for bacterial 
culture and histologic examination. Samples collected for culture included maternal heart 
blood, bile from the gallbladder, a fecal swab, intestinal contents, placenta, fetal stomach 
contents, and fetal tissue homogenate (lung and liver). Swabs for microbial culture were 
obtained using sterile minitip cotton swabs
g 
that were placed in liquid Stuart Transport 
Media
h
. Maternal bile and fetal stomach contents were collected by use of a sterile 
tuberculin syringe with a 26 G, 3/8 inch needle and placed in a sterile tube. Samples of 
uterus, placenta and pooled fetal lung and liver were placed in separate sterile Petri 
dishes. All tissue and fluid samples were immediately refrigerated and cultured on the 
day of collection.  
For semi-quantitative Campylobacter culture approximately 250 microliters of 
bile, blood or fetal stomach contents were directly streaked onto culture media plates 
using a sterile cotton swab. Fecal swabs were directly streaked onto agar media. Placenta, 
uterus as well as pooled fetal and lung tissues were minced with sterile scissors or 
scalpels, swabbed and streaked onto media. The media was MH agar containing a 
Campylobacter selective supplement 
i
 (trimethoprim, rifampicin, polymyxin B and 
cycloheximide) and a Campylobacter growth supplement 
j
 (sodium metabisulfite, sodium 
pyruvate and ferrous sulfate). Incubation took place in sealed jars under micro aerobic 
conditions at 42 °C for 48 hours. Campylobacter-like colonies based on morphology, 
were counted on each plate to determine the number of CFU in each inoculum. 
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Samples for histopathologic examination included maternal liver, gallbladder, 
uterus, placenta, fetal lung and liver. Tissue sections were placed in neutral buffered 10% 
formalin for 24 hours, transferred to 70% alcohol, trimmed and routinely processed.   
 
Immunohistochemistry 
Representative portions of placenta were fixed, processed, embedded and 
sectioned at 3 microns, mounted on aminoalkylsilane-coated glass slides and baked for 2 
hours at 56 
o
C. Slides were deparaffinized routinely in xylene and rehydrated in graded 
alcohol solutions and water. Inhibition of endogenous peroxidase was via 2 immersions 
for 10 mins each in 3% H2O2 in water. Slides were incubated for 15 minutes at 37 °C in 
0.1% protease in Tris buffer of pH 7.6, then rinsed 3 times in PBS solution and stained 
automatically. Nonspecific binding was inhibited by incubation with 10% neutral goat 
serum at 22 °C for 20 minutes. The primary antibody was directed against the major 
outer membrane protein (MOMP) of C. jejuni, as described by Zhang
29
 and Burrough
5
 at 
a dilution of 1:300 and incubated at 22 
o
C for 60 minutes and then rinsed in PBS for 5 
minutes. A commercially available biotinylated secondary antibody (BioGenex, San 
Ramon, CA) was used at a dilution of 1:80 and incubated at 22 
o
C for 15 minutes then 
rinsed in PBS for 5 minutes. Slides were then incubated with horse radish peroxidase-
streptavidin conjugate (Invitrogen, Carlsbad, CA) (1:200 dilution) at 22 
o
C for 15 minutes 
and rinsed in PBS for 5 minutes. The final reaction used a commercial chromogen, Nova 
Red (Vector, Burlingame, CA) for 5 minutes and then slides were rinsed 5 times with 
Ultra-Pure water. Slides were rinsed and routinely counterstained with Shandon Harris 
hematoxylin and Scott’s tap water. Slides were dehydrated through graded alcohol and 
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xylene solutions prior to mounting. Positive controls were sourced from paraffin blocks 
of ovine placenta that was positive for C. jejuni IA3902 by microbial culture. Negative 
controls were obtained from non-infected (Campylobacter-negative) control sheep. 
 
Results 
All inoculated sheep remained clinically normal for the duration of the initial pilot 
study. One DPI, all 3 orally inoculated animals were shedding C. jejuni clone SA 
(confirmed by PCR) in the feces, 2/3 at 2 DPI and 3/3 at 7 DPI (Table 2). 1/3 IP 
inoculated ewe had a positive fecal culture at 7 DPI. No IV inoculated sheep had 
evidence of intestinal colonization prior to the study termination at 20-21 DPI. 
Regardless of the route of inoculation, Campylobacter sp were not cultured from the 
blood, uterus, placenta, fetal lung or fetal stomach content at necropsy. C. jejuni was 
cultured from the feces (2/3 oral, 1/3 IV and 3/3 IP inoculated ewes) and bile (1/3 IV and 
1/3 IP inoculated ewes) at necropsy (Table 4) however, none of these isolates were 
positive for clone SA via PCR. 
In the larger follow-up study all sheep inoculated orally and IP remained 
clinically normal for the duration of the study and Campylobacter sp were not cultured 
from feces, bile, maternal blood, uterus, placenta, fetal lung or fetal stomach content at 
necropsy (Table 5). Of the 6 pregnant ewes that were inoculated intravenously, 3 animals 
were euthanized in extremis, two within 12 hours (received 5mls and 2.25mls of 1.5x10
9
 
CFU/ml each) and one within 24 hours (dose of 2.25mls) post-inoculation. Two ewes 
aborted within 24 hours (2 ewes) and one ewe aborted within 48 hours post-inoculation. 
These animals had received 2, 2.25 and 3mls of 1.5x10
9
 CFU/ml C. jejuni IV, 
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respectively.  There was moderate microbial recovery (50-1000 CFU) from the pooled 
fetal lung and liver and high recovery (>1000 CFU) from the uterus and placenta of one 
ewe (Table 5). Following abortion, these ewes were promptly euthanized, necropsied and 
microbiological, histopathological and immunohistochemical analyses performed  
(Table 6). 
 
Histopathology 
The three IV inoculated ewes that aborted all had consistent histopathologic 
changes in the fetoplacental unit, maternal liver and gallbladder. Within the placentome 
there were multifocal areas with loss of normal fetomaternal placentome architecture, 
composed of loosely arranged aggregates of expanded, often rounded trophoblasts with 
foamy eosinophilic cytoplasm and often pyknotic, karyorrhectic or karyolytic nuclei.  
These aggregates were surrounded by moderate amounts of eosinophilic cellular debris 
and small amounts of extravasated erythrocytes (hemorrhage). Blood vessels were 
markedly congested around these areas (Figure 1A). The submucosa of the uterus was 
mildly expanded by edema with dilated lymphatics and congested blood vessels. 
Endometrial glands were multifocally dilated with eosinophilic material or ectatic with 
large numbers of degenerate and non-degenerate neutrophils (Figure 1B). On the fetal 
side of the placentome, close to the chorioallantoic membrane, there were large foci of 
hemorrhage with hemosiderin laden macrophages and trophoblasts, along with 
accumulations of fibrin, clusters of eosinophilic cellular debris and degenerate 
trophoblasts with pyknotic, karyorrhectic and karyolytic nuclei accompanied by moderate 
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edema in the stroma of the fetal villi and congestion of small vessels within the maternal 
plate with overall loosening of attachment to the body of the placentome.    
In the maternal liver, there were small, random multifocal areas of 
necrosuppurative hepatitis with loss of and necrosis of hepatocytes within these foci and 
infiltration of moderate numbers of neutrophils (Figure 1C).  Within the gallbladder, the 
mucosal architecture was diffusely disrupted, the apical aspect of which was necrotic. 
There is a moderate diffuse neutrophilic infiltration within the lamina propria separating 
and surrounding glands and multifocal lymphoid follicles. Vessels in the lamina propria 
were congested and there were foci of hemorrhage (Figure 1D). 
 
Immunohistochemistry 
In one IV inoculated ewe that aborted and from which high levels of C. jejuni 
were isolated from the placenta and uterus (Table 4), there was positive staining in 
degenerate trophoblasts for C. jejuni as determined by MOMP-specific antibody (Figure 
1E). There was also positive staining for the MOMP within endometrial gland content 
(Figure 1F) and within fetal villi (Figure 1G) of that same animal. There was complete 
lack of staining for MOMP in other inoculated sheep and in negative control placenta. 
 
Discussion 
Oral administration of high doses of C. jejuni to pregnant sheep did not result in 
fetoplacental infection, abortion or intestinal colonization. Similarly, high doses 
administered via the IP route, did not cause clinical signs of ill health, peritonitis, 
fetoplacental infection or abortion. High IV doses of C. jejuni induced abortion and the 
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organism was recovered in high numbers from the placenta and uterus of one ewe, while 
moderate numbers were recovered from the lung and liver of the aborted fetus. There 
were degenerative histological changes in the placentome of this animal with rounded, 
swollen trophoblasts and cellular and nuclear debris we well as vascular congestion and 
hemorrhage. Immunohistochemistry (IHC) confirmed the presence of the organism 
within trophoblasts, fetal villi and endometrial glands.  
The oral route has been used to successfully replicate C. jejuni IA3902 induced 
reproductive disease in mice (Lashley, submitted for publication), guinea pigs,
5
 and 
occasionally in sheep,
23
 though usually at a lower rate than parenteral routes. The oral 
route of inoculation replicates the natural route of infection in sheep and represents the 
preferred model to study disease pathogenesis, organism virulence factors, and assess 
protective immunity in sheep. In the Pilot study, there was evidence of intestinal 
colonization from clone SA positive fecal cultures up to 7 DPI but not at 20-21 DPI. This 
indicates that intestinal colonization by clone SA did not occur or it was only transient. 
Additionally, the levels of specific serum antibody did not change appreciably by ELISA, 
further supporting the lack of colonization followed by translocation to the bloodstream 
by clone SA in the ewes (Table 7). Therefore, despite the instillation of massive numbers 
of organisms orally (up to 50 mls of 2.1x10
10
 CFU/ml C jejuni IA3902 in the larger 
study), we were not able to successfully induce fetoplacental infection, abortion or 
establish intestinal colonization for up to 21 DPI following oral administration of the 
organism to pregnant sheep. While this may be due to multifactorial reasons, the ability 
of the organism to adequately colonize and invade the gastrointestinal mucosa may be the 
most influential factor. The ewes in this study had low titers to C. jejuni, which may have 
93 
 
contributed to protection against intestinal colonization by the organism.
13
  Secretory IgA 
is the major immunoglobulin isotype in mucosal secretions and generally responsible for 
preventing subepithelial translocation of commensal bacteria by preventing their 
adhesion to epithelial cells or returning bacteria that already reached the basolateral site, 
without eliciting an inflammatory response.
3,8
  
IV inoculated sheep in this study had histopathological lesions in the liver and 
gallbladder 
5
 similar to lesions identified in guinea pigs and mice orally inoculated with 
C. jejuni IA3902 (submitted for publication).  Liver lesions in all three species consisted 
of a multifocal necrosuppurative hepatitis speculated to be the result of 
campylobacteremia.
14,20
 In the larger study, while histopathological changes were noted 
primarily in the mucosa and submucosa of the gallbladder, the organism was not cultured 
from bile. Alternatively, it is possible that 48 hours post inoculation was not sufficient 
time for adequate gallbladder colonization. There was high recovery of the organism 
(>1000 CFU) from the bile of an IV inoculated ewe in the pilot study cultured 21 DPI. 
Gallbladder colonization following infection has been reported with both C. fetus 
4,7
 and 
C. jejuni 
11,21
 and this feature likely plays a major role in the maintenance of infection 
within sheep populations.
10,15
 The role and effect of endotoxin in producing related 
histological lesions are unknown.    
The IP route of inoculation has been used to successfully replicate C. jejuni 
IA3902 induced reproductive disease in both guinea pigs and mice.  In both species, IP 
inoculation resulted in 100% fetoplacental infection 
5
 (Lashley, submitted for 
publication), and this challenge route has been described in a model for assessing 
virulence of Campylobacter spp.
27
 Although IP inoculation does not replicate the natural 
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route of oral exposure by abortifacient Campylobacter spp,
17
 IP challenge of pregnant 
ewes was incorporated into this study because of the success of this route in other species 
and because  IP administration would potentially delay access of bacteria and endotoxin 
into the systemic circulation with the aim of diminishing the rapid systemic impact of 
endotoxin.  Drug absorption following IP administration is reported to be one quarter to 
one half as fast as that from the IV route.
24
 In our studies, even when sheep were 
administered large doses, up to 6ml of 5x10
9
 CFU/ml IP, they failed to develop clinical 
signs, peritonitis, fetoplacental infection or abortion.  
IV inoculation enables immediate dispersal of the inoculum into the vascular 
system, allowing rapid exposure to all tissues, including susceptible sites like the 
fetoplacental unit. IV inoculation of sheep has led to fetoplacental infection in two other 
studies,
23,12
 albeit in a very limited numbers of animals.  Based on the results of our 
studies, the dose used for IV inoculation appears to be a crucial factor. A low dose failed 
to result in fetoplacental infection and abortion. High IV doses did result in fetoplacental 
infection but were met with severe adverse consequences, likely as a result of the 
endotoxin, leading to the necessity to euthanize animals in extremis within 24 hours of 
inoculation. The findings in this study are similar to what was found by Sanad et al., 
2014 where one ewe died 20 h after IV inoculation with 1.5 mls of 10
9
 CFU of the C. 
jejuni ovine isolate of the abortion associated tetracycline resistant clone SA.   
Endotoxins are lipopolysaccharides (LPS) derived from the cell membranes of 
Gram negative bacteria, like C. jejuni, and are mainly released during bacterial growth, 
multiplication and death.  Exposure to high systemic levels can result in endotoxic shock, 
tissue injury and death of the infected animal.
16
 In the initial pilot study C. jejuni IA3902 
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cultures were washed in sterile PBS to remove free endotoxin and 1ml of 1x10
8
 CFU/ml 
was administered IV.  Following inoculation, ewes became slightly depressed and 
somewhat inappetent for approximately 24 hours, after which time they appeared normal.  
However, this IV dose failed to result in fetoplacental infection or abortion.  Higher IV 
doses (2-5ml of 1.5x10
9
 CFU/ml) of unwashed cultures did result in fetoplacental 
infection but were met with severe adverse consequences typical of endotoxic shock, 
including marked depression, anorexia, elevated heart rate, cool extremities, and 
petechial hemorrhages on the mucous membranes.  These severe clinical signs   
necessitated the euthanasia of all 6 ewes within 12-48 hours post-challenge.  Though the 
organism was isolated from the fetoplacental unit of three ewes and acute inflammation 
was identified in the uterus and placenta, the full range of gross and histological lesions 
typifying field cases of Campylobacter abortion were not seen. This is not surprising 
considering that the ewes aborted within 24 and 48 hours post IV inoculation. Therefore, 
in this study, it is likely that endotoxic shock was a primary contributing factor in the 
early reproductive loss in these animals.  Future studies will be aimed at mitigating the 
effects of endotoxin by washing cultures prior to IV administration and premedicating 
ewes with non-steroidal anti-inflammatory drugs (NSAIDs) in an attempt to ameliorate 
the clinical effects of high levels of endotoxin in the blood. 
Immunohistochemical procedures were based on the use of antibodies for MOMP 
protein. The MOMP of C. jejuni, a porin and adhesin,
18
  has a vital role in producing 
systemic infection and abortion. IHC confirmed the presence of the organism within 
trophoblasts which is in agreement with studies in sheep,
23,12
 guinea pigs 
5
 and mice 
(submitted for publication). As far as we could determine, this is the first report of the 
96 
 
organism within fetal villi and endometrial glands of infected ovine reproductive tissues. 
As was found in the guinea pig study, immunohistochemical analysis in the sheep 
placenta was less sensitive than microbial culture as a means of detecting C. jejuni in 
tissues, which is consistent with results in other studies.
6,28
 
In a pregnant sheep infected with C. jejuni, the organism spreads hematogenously 
from the gastrointestinal tract to the female reproductive tract resulting in uterine and 
feto-placental infection.
2
  Infected ovine placenta has been reported to have necrotic villi 
with large colonies of C. jejuni within trophoblasts lining chorionic villi, subjacent 
stroma, vascular endothelium and blood vessel lumen and also within uterine 
leukocytes.
12
  In this study the presence of C. jejuni within trophoblasts of the ovine 
placenta was confirmed via IHC in one animal. Trophoblast infection is likely to be a 
crucial step in the transfer of infection across the placenta and may occur by direct 
invasion of bacteria or transcellular migration to and from infected macrophages.
1
     
In field cases of C. jejuni abortion in sheep, fetal bronchopneumonia has been 
reported as a consistent finding as well as multifocal hepatic necrosis,
12
  however these 
lesions were not identified in fetal tissue in our studies, possibly due to the short time 
interval from inoculation to abortion. Since low levels of C. jejuni were isolated from 
pooled fetal lung and liver, it is likely that lesions in these fetal tissues would have 
developed had the incubation period been a more typical length (8-10 days).   
Enzyme linked immunosorbance assay (ELISA) was performed to determine 
serum titer levels to C. jejuni before each study and only sheep that had negligible titre 
levels were used. Despite this, the possible role of immunity to the pathogen cannot be 
completely ruled out as a compounding factor. The use of naïve pregnant ewes cannot be 
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overemphasized for future studies. Despite pre-inoculation fecal testing showing little or 
no Campylobacter sp shedding, the possible role of natural C. jejuni intestinal, albeit 
intermittent colonization and its influence is unknown.  
The oral route of inoculation replicates the natural route of infection in sheep and 
represents the preferred model.  Unfortunately, the only inoculation route that resulted in 
fetoplacental infection in this study was IV.  It is possible that organism fitness played a 
role in the inability to establish intestinal colonization and eventual fetoplacental 
infection following oral challenge. C. jejuni isolated from the intestines of chicks and 
then re-inoculated into other chicks resulted in cecal colonization to a much greater 
degree, presumably due to increased organism fitness.
13
 If the fitness of cultured 
Campylobacter is a concern, consistent fetoplacental infection following IV challenge 
may prove useful as the initial stage of generating infectious material. Infected placenta 
from abortions following IV inoculation may represent a more productive oral inoculum 
source. 
 
Conclusion 
Three separate routes of inoculation were evaluated in pregnant ewes to try and 
replicate abortion due to C. jejuni.  At the doses administered, neither oral nor IP 
administration of the organism induced abortion.  IV inoculation caused relatively 
consistent fetoplacental infection, but the high doses necessary resulted in severe adverse 
effects in the ewes attributed to endotoxin, and abortions occurred much more rapidly (1-
2 days) than is typically reported in field infections. In a ewe that aborted 48 hours post 
IV inoculation, C. jejuni was recovered in high numbers from the placenta and uterus and 
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in moderate numbers from the lung and liver of the aborted fetus. There were 
degenerative histological changes in the placentome of this animal with rounded, swollen 
trophoblasts and cellular and nuclear debris we well as vascular congestion and 
hemorrhage. Immunohistochemistry (IHC) confirmed the presence of the organism 
within trophoblasts, fetal villi and endometrial glands. As far as we could determine, this 
is the first report of the organism within fetal villi and endometrial glands of infected 
ovine reproductive tissues. Future studies will be aimed at mitigating the effects of 
endotoxin by washing the cultures prior to IV administration and premedicating ewes 
with non-steroidal anti-inflammatory drugs (NSAIDs). As oral administration of a highly 
virulent strain of cultured C. jejuni failed to result in fetoplacental infection, oral 
administration of infectious placenta from IV challenged ewes will be considered for 
future studies.  
 
Footnotes 
a. Envigo, Madison, WI 
b, c. Fisher Scientific, Pittsburgh, PA 
d,. Xttrium Laboratories Inc, Mt. Prospect, IL 
e. Science Lab, Houston, TX 
f. Merck Animal Health, Madison, NJ 
g. BBL CultureSwab, Becton-Dickinson Co, Franklin Lakes, NJ 
h. Fisher Scientific, Pittsburgh, PA 
i. Preston Campylobacter selective supplement, Oxoid Ltd, Cambridge, England 
j. Campylobacter growth supplement, Oxoid Ltd, Cambridge, England 
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Table 1.  Dose and animal distribution for the Pilot study and Larger study 
 
 Dose in January 2016 
(CFU/ml) 
Dose in May 2016 
(CFU/ml) 
Group 1 (Oral challenge)   
O1 20mls of 1x109  50 ml of 2.1x1010  
O2 20mls of 1x109 50 ml of 2.1x1010 
O3 20mls of 1x109 50 ml of 2.1x1010 
Group 2 (IV challenge)   
IV1 1ml of 1x108  2.25ml of 1.5x109  
IV2 1ml of 1x108  2.25ml of 1.5x109  
IV3 1ml of 1x108  2.25ml of 1.5x109  
IV4  3ml of 1.5x109  
IV5  5ml of 1.5x109  
IV8  2ml of 1.5x109  
Group 3 (IP challenge)   
IP1 1ml of 1x108 5ml of 5x109  
IP2 1ml of 1x108  6ml of 5x109  
IP3 1ml of 1x108  6ml of 5x109  
IP4  6ml of 5x109  
IP5  5ml of 5x109  
IP6  5ml of 5x109  
 
 
 
 
Table 2. Pilot Study. Rectal temperatures, fecal cultures and clone SA result by PCR 
at 0, 1, 2 and 7 DPI 
 
ROUTE 
OF 
INOCUL
ATION 
DAYS POST INOCULATION (DPI) 
  0 1 2 7 
Oral  
Rectal 
Temp 
Fecal 
culture 
Clone 
SA 
PCR 
Rectal 
Temp 
Fecal 
culture 
Clone 
SA 
PCR 
Rectal 
Temp 
Fecal 
culture 
Clone 
SA 
PCR 
Fecal 
culture 
Clone 
SA 
PCR 
O1 101.7 0 
 
102.3 2 +ve 102.2 3 
 
65 +ve 
O2 101.8 TNTC -ve 102.5 3218 +ve 102.7 161 +ve 6 +ve 
O3 101.1 0 
 
103.1 7 +ve 102.2 86 +ve 537 +ve 
IV 
           
I1 102.5 121 -ve 103.3 53 -ve 103.3 67 -ve 2417 -ve 
I2 102.2 53 -ve 102.7 13 
 
102.5 9 -ve 0 
 
I3 102.3 0 
 
102.4 0 
 
102.4 0 
 
0 
 
IP 
           
P1 101.4 16 -ve 102.4 1 -ve 102.4 0 
 
8 +ve 
P2 100.5 3 -ve 102.7 7 -ve 102.9 0 
 
12 -ve 
P3 102.2 89 -ve 101.8 47 -ve 102.2 71 -ve  7 -ve  
  Negative = -ve, Positive = +ve 
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Table 3. Pilot Study. Sample source and semiquantitative recovery of C. jejuni 
IA3902 cultured from pregnant ewes at necropsy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*values reported represent number of samples with positive culture results/number of samples tested. §Results reported  
represent number of samples within that category/number of samples with positive culture results.  
 
 
 
 
 
 
Table 4. Larger study. Fecal and enriched culture data for oral and IP inoculated 
ewes at 0, 4 and 11 DPI. 
 
Route 
of 
Inocula
tion 
DPI 
0 4 11 
Oral Fecal  
No 
enrich-
ed data 
Fecal  Fecal (enriched) Fecal  Fecal (enriched) 
       
1 0 
 
0 23(not jejuni) 30(not jejuni) 0 
2 0 
 
0 14(not jejuni) 17(not jejuni) lawn(not campy) 
3 0 
 
0 lawn, white(not Campy) 
white not campy 
(110) 
871(not campy) 
IP  
      
6 
      
5 0 
 
0 lawn, white(not Campy) 0 772 not campy 
4 0 
 
0 70(not jejuni) 4(not jejuni) 40(not jejuni) 
3 
8(campy, 
not jejuni)  
0 40(not jejuni) 9(not jejuni) 4 (not jejuni) 
8 0 
 
0 lawn, white(not Campy) 2(not jejuni) TNTC not campy 
9 
30(white, 
not 
campy) 
 
0 lawn, white(not Campy) 11(not jejuni) lawn not campy 
  0   0 24(not jejuni) 4(not jejuni) lawn not campy 
 
 
 
 
Route of 
inoculation 
Volume and 
concentration of the 
inoculum (CFU/ml) 
Number of 
samples culture 
positive* 
Low recovery 
(<50 CFU) § 
Moderate 
recovery (50-
1000 CFU) § 
High recovery 
(>1000 CFU) § 
  Feces Bile Feces Bile Feces Bile Feces Bile 
Oral 20mls of 1x10^9  2/3 0/3 2/2 0/0 0/2 0/0 0/2 0/0 
IV 1ml of 1x10^8  1/3 1/3 0/1 0/1 1/1 0/1 0/1 1/1 
IP 1ml of 1x10^8  3/3 1/3 3/3 0/1 0/3 1/1 0/3 0/1 
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 Table 5. Larger study. Sample source and semiquantitative recovery of C. jejuni 
IA3902 cultured from pregnant ewes at necropsy.  
*values reported represent number of samples with positive culture results/number of samples tested. §Results reported represent 
number of samples within that category/number of samples with positive culture results. Data in red from one ewe that aborted at 48 
hours post inoculation. 
 
 
 
 
 
 
 
Table 6. Summary of clinical findings with microbiological, histopathological and 
immunohistochemical correlates.    
 
 Ewes from the IV group that aborted during the study 
Ewe ID 
(dose of inoculum 
administered) 
IV 2 
(2.25mls) 
IV 4 
(3mls) 
IV 8 
(2mls) 
Days post inoculation 
for abortion 
2 1 1 
Clinical signs post 
inoculation 
 
Increased rate and depth of 
respiration, sternal 
recumbency, temp within 
normal range 
 
 
Increased rate and depth 
of respiration, sternal 
recumbency, temp 
within normal range, 
loose stool 
 
Clinically normal 
Microbial culture 
results 
 
Uterus +++ 
  
Placenta +++ Placenta + Placenta + 
Fetus (lung and liver) ++ 
 
  
Histopathology 
Placentitis, endometritis, 
cholecystitis 
Placentitis, 
endometritis, 
cholecystitis 
Placentitis, 
endometritis, 
cholecystitis 
Immunohistochemistry 
for MOMP 
Positive identification of C. 
jejuni in trophoblasts, fetal villi 
and endometrial glands 
C. jejuni could not be 
confirmed 
C. jejuni could not be 
confirmed 
+ = Low recovery (<50 CFU), ++ = Moderate recovery (50-1000 CFU), +++ = High recovery (>1000 CFU) 
 
 
Route 
of 
inocula
tion 
Number of samples 
culture positive* 
Low recovery (<50 
CFUs) § 
Moderate recovery (50-
1000 CFUs) § 
 
High recovery (>1000 
CFUs) § 
 
 Uterus Placenta 
Pooled 
fetal lung 
and liver 
Uterus Placenta 
Pooled 
fetal lung 
and liver 
Uterus Placenta 
Pooled 
fetal lung 
and liver 
Uterus Placenta 
Pooled 
fetal lung 
and liver 
Oral 0/3 0/3 0 0 0 0 0 0 0 0 0 0 
IV 2/6 3/6 1/1 1/2 2/3 0/1 0/2 0/3 1/1 1/2 1/3 0/1 
IP 0/6 0/6 0 0 0 0 0 0 0 0 0 0 
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Table 7. Pilot Study. ELISA optical density (OD) at 0 and 21 DPI for ewes 
inoculated by all routes 
 
ROUTE 
OF 
INOCUL
ATION 
DAYS POST INNOCULATION (DPI) 
 
0 21 
Oral 
ELISA OD 
1 
ELISA OD 
2 
Average 
OD 
ELISA OD 1 ELISA OD 2 Average OD 
O1 0.315 0.289 0.302 0.333 0.374 0.3535 
O2 0.325 0.322 0.3235 0.323 0.33 0.3265 
O3 0.276 0.246 0.261 0.215 0.215 0.23033333 
IV 
      
I1 0.311 0.28 0.2955 0.333 0.357 0.345 
I2 0.225 0.25 0.2375 0.336 0.285 0.3105 
I3 0.329 0.315 0.322 0.286 0.318 0.302 
IP 
      
P1 0.362 0.363 0.3625 0.348 0.327 0.3375 
P2 0.362 0.389 0.3755 0.212 0.224 0.218 
P3 0.294 0.258 0.276 0.29 0.277 0.2835 
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Figure 1. Photomicrographs of ovine placenta, endometrial glands, liver and 
gallbladder after inoculation with C. jejuni IA3902. (A) H&E of placentome section 
with fetal villi lined by trophoblasts, loss of architecture and congested blood vessels. (B) 
H&E – large numbers of neutrophils within endometrial glands (C) H&E of liver – foci 
of necrosis and neutrophil accumulation  (D) H&E of the gallbladder – mucosal 
architecture is diffusely disrupted, the apical aspect is necrotic, there is moderate diffuse 
neutrophilic infiltration within the lamina propria separating and surrounding glands and 
multifocal lymphoid follicles with vascular congestion and hemorrhage. (E) IHC for the 
membrane outer protein of C. jejuni (MOMP), foci of positive stain within endometrial 
gland content (F) IHC for the membrane outer protein of C. jejuni (MOMP), foci of 
positive stain within endometrial gland content, foci of positive stain within fetal villi. 
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Abstract 
Campylobacter jejuni (C. jejuni) is a foodborne pathogen that causes enteritis in 
humans and abortion in ruminants.
13
 An antibiotic resistant, hypervirulent clone, clone 
sheep abortion (SA), is the agent responsible for over 90% of Campylobacter abortions in 
US sheep.
30
  This study investigated potential trophic factors for this pathogen within the 
sheep placenta and explored possible abortifacient mechanisms of action of the organism. 
Pregnant sheep were inoculated intravenously with C. jejuni IA3902, a representative 
isolate of clone SA. After abortion, the organism was isolated in high numbers from the 
placenta and uterus.  Immunohistochemistry (IHC) for the major outer membrane protein 
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(MOMP) of the bacteria established the location of the pathogen in the placenta. Special 
stains and lectin IHC determined the distribution of known trophic factors for C. jejuni, 
including neutral and acid mucin, iron stores and L-fucose in the uterus and placenta. A 
commercial assay was used for apoptosis detection. IHC was used to assess caspase 3, 
Toll-like receptor 4 (TLR4) and transcription of nuclear factor kappa-light-chain-
enhancer of activated B cells (NFκB). C. jejuni localized to areas in the ovine 
fetoplacental unit and uterus where there were significant amounts of neutral and acid 
mucin, including the fetal villi and endometrial glands and where L-fucose and iron was 
present, also within endometrial glands. There was abundant, multifocal, cytoplasmic 
staining of stromal cells and trophoblasts of the chorioallantoic villi for caspase 3 and 
multifocal, abundant staining of TLR4 within chorioallantoic membranes. There was no 
difference in NFκB signal from infected or uninfected tissues. 
 
Introduction 
C. jejuni is a Gram negative bacterium that causes significant numbers of sheep 
abortions with associated economic loss to sheep producers and is a zoonotic 
gastroenteric human pathogen. The majority of Campylobacter abortions in US sheep is 
currently associated with a specific clone of C. jejuni, designated as the SA clone, 
typified by C. jejuni isolate IA3902. C. jejuni routinely colonizes the intestines of 
sheep,
29
 is frequently isolated from the ovine gall bladder 
10
 and has an affinity for the 
fetoplacental unit in this ruminant species.
14
 Studies have indicated that C. jejuni IA3902 
has strong chemo attraction towards mucin and L-fucose, two agents that also supported 
109 
 
growth of the organism.
8
 In that study, iron, mucin and L-fucose were demonstrated to be 
present within the guinea pig placenta in areas where C. jejuni was localized by 
immunohistochemistry. One goal of this study was to ascertain the distribution and 
amount of these factors in infected ovine placenta and to ascertain whether the organism 
also localized in those areas.  
Lipopolysaccharide from Gram negative bacteria like C. jejuni activate TLR4 
mediated NFκB signaling pathways resulting in a proinflammatory response.12  NFκB is 
a pleotropic initial-response transcription factor that leads to the expression of genes 
associated with immunological and inflammatory responses and was found to be 
activated by the intracellular entry of C. jejuni in vitro.
21
 TLR4 signaling was the primary 
agent for the enteritic alterations observed in a murine model of C. jejuni infection.
28
  
However, TLR 4 was not upregulated in guinea pig placenta infected with 
Campylobacter.
6
   
Apoptosis is the highly regulated process of cellular death with intrinsic and 
extrinsic pathways that eventually converge in the generation of executioner caspases, 
caspase 3 and caspase 7.
16
 Caspases are cellular endoproteases that control inflammation 
and cell death via the production of activated proinflammatory cytokines.
20
 Caspase 3 is a 
member of the interleukin-1 β-converting enzyme family and is thought to be associated 
with the induction of apoptosis.
17
 It is present within the cytoplasm as an inactive 
proenzyme that is activated during apoptosis. Caspase 3 is an ‘effector’ caspase that 
initiates the ‘death cascade’ and is a central biomarker of apoptosis.3 High levels of 
caspase 3 were detected in mixed viral and bacterial urogenital infections suggesting 
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increased placental cell death and the triggering of placental dysfunction by this 
mechanism.
25
 
Another aim was to evaluate factors that contribute to C. jejuni’s trophism for 
ovine fetoplacental tissue by assessing the distribution and amount of known trophic 
factors for C. jejuni in infected ovine placenta and to ascertain whether the organism also 
localized in these areas.  
 In order to develop an appreciation for the mechanisms that lead to abortion 
following fetoplacental C. jejuni infection, an apoptosis assay was conducted as well as 
analysis of an important mediator of apoptosis, specifically caspase 3. TLR4 and NFκB 
have been reported to be responsible for the majority of intestinal inflammation and the 
associated enteric pathology caused by C. jejuni. The role that TLR4 and NFκB may play 
in causing reproductive pathology and abortion has not been previously reported. 
 
Materials and Methods 
C. jejuni infected ovine placenta was obtained from a recent live animal study as 
well as a 2015 field case of abortion obtained from the Veterinary Diagnostic Laboratory, 
Iowa State University from which C. jejuni clone SA was isolated.  In the live animal 
study, six pregnant ewes were inoculated intravenously (IV) with 2-5 mls of 1.5x10
9
 
colony forming units (CFU)/ml C. jejuni IA3902, 40-45 days prior to lambing. The ewes 
were first time single and twin pregnant whiteface and black-whiteface crosses, sourced 
from the Iowa State University Sheep Teaching facility and from which pre-inoculation 
serology testing showed very low levels of C. jejuni specific antibodies via Enzyme 
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Linked Immunosorbent Assay (ELISA). Campylobacter was not isolated from a pre-
inoculation rectal swab from any of the IV inoculated ewes either by culture of a direct 
fecal smear or fecal enrichment. Ewes were housed in individual pens in an ABSL 2 
facility and were identified via ear tags and individual cage identification. Ewes were fed 
Teklad-Envigo 7060 small ruminant complete ration with water available ad lib. A group 
of 6 ewes was inoculated IV via an 18G, 2 inch long IV catheter placed in the jugular 
vein. The inoculation site was sheared and aseptically prepared using alternate 
Chlorhexidine
®
 (chlorhexidine gluconate 2.0%) and Isopropyl alcohol (70%) swabs 
performed three times.  The ewes received 2.0, 2.5 (3), 3.0 and 5.0 mls of 1.5x10
9
 
CFU/ml C jejuni IA3902.  
Ewes were monitored three times per day for signs of ill health including 
depression, loss of appetite, prolonged recumbency, elevated temperatures, and abortion 
(genital bleeding, expelled fetus). Ewes that aborted were immediately euthanized with 
euthanasia solution (Beuthanasia
®
, sodium pentobarbital 390mg + sodium phenytoin 50 
mg/ml) at 0.22mg/kg, intravenously using an 18 G needle, as per AVMA Guidelines on 
Euthanasia (AVMA, 2013).  
Inspection for gross lesions and sample collection for bacterial culture and 
histologic examination were undertaken at necropsy. Samples collected for culture 
included maternal heart blood, bile from the gallbladder, fecal swab, intestinal contents, 
placenta, fetal stomach content, and fetal tissue homogenate (lung and liver). Swabs for 
microbial culture were sterile minitip cotton swabs with transport media. Fetal bile and 
stomach contents were collected by use of a sterile tuberculin syringe with a 26 G, 3/8 
inch needle. Samples of uterus, placenta and pooled fetal lung and liver were placed in 
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separate sterile Petri dishes. Samples were immediately refrigerated after collection and 
bacterial culture was done on the day of collection,  
For Campylobacter culture and semiquantitative enumeration of C. jejuni from 
necropsy samples approximately 250 microliters of bile, blood or fetal stomach contents 
were directly streaked onto culture media plates using a sterile cotton swab. Fecal swabs 
were directly streaked onto media. Placenta and uterus as well as pooled fetal and lung 
tissues were minced with sterile scissors or scalpels, swabbed and streaked onto media. 
The media was MH agar containing a Campylobacter selective supplement 
(trimethoprim, rifampicin, polymyxin B and cycloheximide) and a Campylobacter 
growth supplement (sodium metabisulfite, sodium pyruvate and ferrous sulfate). 
Incubation took place in anaerobic jars under micro aerobic conditions at 42 °C for 48 
hours. Campylobacter-like colonies were counted on each plate to determine the number 
of CFU in each sample. 
Samples harvested for histopathology included uterus, liver and gallbladder from 
each ewe, placenta, fetal lung and liver. Tissues for histopathology were placed in neutral 
buffered 10% formalin for 24 hours then transferred to 70% alcohol.  
 
Special stains 
Perls’ iron stain, Alcian blue pH 2.5 for acid mucins and the Periodic acid-schiff 
(PAS) reaction with and without diastase pretreatment for neutral mucins were performed 
on sections of ovine placenta confirmed positive by microbial culture and 
immunohistochemistry for C. jejuni. Serial sections were cut to 5 µm, stained and 
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assessed to determine the presence or absence of stained material with characteristics 
consistent with iron, acid mucin and neutral mucin within the placentome, chorioallantoic 
membrane, endometrium and endometrial glands. Staining was subjectively classified as 
low/absent, moderate or abundant, intracellular, extracellular, multifocal or diffuse. 
 
Lectin Histochemistry 
This technique follows the protocol described by Burrough et al., 2012. Three 
micron (3 µm) serial sections were set on aminoalkylsilane-coated glass slides, baked at 
56 
o
C for 2 hours and routinely deparaffinized in xylene and rehydrated in graded alcohol 
solutions and water baths. Endogenous peroxidase inhibition was achieved by immersion 
(2 immersions; 10 min/immersion) in baths of 3% hydrogen peroxide (H2O2) in water. 
Antigen was unmasked by treating sections with Tris-EDTA (pH 9.0) in a stream bath for 
20 minutes, cooled to room temperature, and rinsed 3 times in phosphate buffered saline 
(PBS) prior to placement in an automated cell staining system (BioGenex, US). The 
lectin used was the commercially available biotinylated Lotus tetragonolobus lectin 
agglutinin I (LTA; Vector, US) at a dilution of 1:100, and incubated at 22 
o
C for 30 
minutes, followed by rinsing in a bath of PBS solution for 5 minutes.
8
  Lectin binding 
was visualized using a commercial kit (Vectastain Elite ABC, Vector) and chromogen 
(NovaRED, Vector) as per the manufacturer’s instructions; the sections were then 
counterstained with hematoxylin and mounted routinely. Specificity of lectin binding was 
confirmed by preabsorbing lectins in 250 mM of L-fucose prior to application to serial 
sections. Negative controls were prepared from serial sections with the lectin omitted and 
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replaced with dilution buffer. Lectin binding was subjectively quantified in the 
placentome, chorioallantoic membranes, endometrium and endometrial glands as 
low/absent, moderate or abundant and whether cytoplasmic or membranous. 
 
Immunohistochemistry 
Immunohistochemical analysis was performed for TLR4, NFκB and Caspase 3 on 
ovine placenta sections for which there was positive microbial recovery and positive 
MOMP antigen detection. These criteria were also applied to a recently confirmed C. 
jejuni positive field case that was obtained from the Veterinary Diagnostic Laboratory of 
Iowa State University and included here as a positive control. Healthy, confirmed 
uninfected ovine placenta was sourced as a negative control. Placenta collected at 
necropsy and embedded were sectioned at 3 microns, mounted on aminoalkylsilane-
coated glass slides and baked for 30 minutes for at least 57 
o
C (2 hours at 56 
o
C for 
MOMP).
32
  Slides were deparaffinized routinely in xylene and rehydrated in graded 
alcohol solutions and water. Inhibition of endogenous peroxidase was via 2 immersions 
for 10 mins each in 3% H2O2 in water followed by 3 rinses in Ultra-Pure water. Slides 
were incubated for specific times at temperatures and in various antigen retrieval buffers 
(Table 1), then rinsed 3 times in PBS solution and stained automatically (BioGenex, San 
Ramon, CA). Nonspecific binding was inhibited by incubation with 10% neutral goat 
serum at 22
o
C for 20 minutes. The primary antibody used to detect C. jejuni was directed 
against the MOMP of the organism as described by Zhang
33
  and Burrough
7
  and used at 
dilution of 1:300. Antibodies directed against TLR4, NFκB and caspase 3 (Abcam, 
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Cambridge, MA) were each at dilutions of 1:100, and incubated at 22
o
C for specific times 
(Table 1), followed by 2 PBS rinses, a 5 minute PBS bath and then 2 PBS rinses. A 
commercially available biotinylated secondary antibody (BioGenex) was used at a 
dilution of 1:80 and incubated at 22
o
C for 15 minutes followed by 2 PBS rinses, a 5 
minute PBS bath and then 2 PBS rinses. Slides were then incubated with horse radish 
peroxidase-streptavidin conjugate (Invitrogen, Carlsbad, CA) (1:200 dilution) at 22
o
C for 
15 minutes followed by 2 PBS rinses, a 5 minute PBS bath and then 2 PBS rinses. The 
final reaction used a commercial chromogen, Nova Red (Vector, Burlingame, CA) for 5 
minutes and then rinsed 5 times with Ultra-Pure water. Slides were routinely 
counterstained with Shandon Harris hematoxylin and Scott’s tap water. Slides were 
dehydrated through graded alcohol and xylene solutions prior to mounting. Positive 
controls were sourced from paraffin blocks of ovine placenta that was positive for C. 
jejuni IA3902 by microbial culture. Negative controls were obtained from uninfected 
control sheep. Internal controls were also included. 
 
Apoptosis detection 
The cascade of biochemical and molecular events that result in apoptosis involves 
endonucleases that cleave DNA in fragments with free 3’-OH groups at the ends which 
can be labeled and detected. In situ hybridization can be used to recognize and enable an 
understanding of the spatial distribution of apoptotic nuclei via detection of these labeled 
DNA fragments in paraffin-embedded ovine placental tissues. The Abcam In situ 
Apoptosis Detection Kit
® was used according to manufacturer’s instructions via 
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completion of multiple steps in a standard IHC based assay. Slides were cut to 10 um and 
rehydrated. Reagents were thawed 30 mins prior to use, tissue was permeabilized using 
Proteinase K, endogenous peroxide was inactivated using 3% H2O2 for specified times. 
Tissues were labelled with TdT Enzyme, blocked with proprietary blocking buffer, 
incubated with conjugate and incubated with assay prepared DAB solution, 
counterstained with methyl green counterstain; dehydrated, cover-slipped and evaluated 
using an Olympus light microscope.   
In this apoptosis assay, terminal deoxynucleotidyl transferase (TdT) binds to 
exposed 3’-OH ends of DNA fragments and catalyzes the binding of biotin-labeled 
deoxynucleotides which are detected using a streptavidin-horseradish peroxidase (HRP) 
conjugate. Diaminobenzidine (DAB) reacts with the HRP-labeled tissue section to 
produce an insoluble brown substrate at the location of the fragmented DNA. Methyl 
green was used to aid morphological evaluation of normal and apoptotic cells. 
1
 
The IHC method used to detect caspase 3 in this study was a very specific and 
sensitive method to identify apoptotic cells in paraffin-embedded tissue. This is because 
Caspase 3 is normally present intracellularly as a procaspase and once cleaved through 
the activation of the apoptotic cascade mediates further cleavage of itself and other 
downstream caspases and therefore its detection is a unique and sensitive indicator of 
apoptosis.
11
  
Results 
One sheep that was inoculated with 2.25mls C. jejuni IA3902 IV and aborted 48 
hours post inoculation, had high microbial recovery (>1000 CFU) of C. jejuni from the 
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uterus and placenta and moderate microbial recovery (50-1000 CFU) from fetal lung and 
liver. There was positive red-brown staining for the MOMP C. jejuni within trophoblasts 
of the placentome, within the lumen of endometrial glands (Figure 1) and within fetal 
chorionic villi (Figure 2) in this animal.  
PAS stains were utilized to detect neutral mucins.  There was moderate diffuse 
PAS positive staining of placentome basement membranes and trophoblasts of the 
chorioallantoic membranes had abundant, multifocal cytoplasmic staining. Within the 
endometrium, there were moderate amounts of staining for neutral mucins at the apical 
membrane and occasional low cytoplasmic staining. There was abundant staining for 
neutral mucins multifocally within endometrial glands (Figure 3).  
Alcian blue stains were utilized to detect acid mucins. Diffusely, the stroma of the 
endometrium, fetal villi of the placentome (Figure 4) and chorioallantoic membranes had 
abundant positive staining for neutral mucins.  Multifocally at the apical aspect of cell 
membranes of the endometrium and endometrial glands, there was abundant alcian blue 
positive staining for acid mucin.  
There was low iron staining multifocally within the placentome and 
chorioallantoic membranes. These were located within trophoblast cytoplasm or as 
occasional extracellular deposits. There was also rare extracellular staining for iron 
within luminal content of endometrial glands in small amounts (Table 2).  
Lotus tetragonolobus (LTA) lectin-peroxidase conjugates are specific for fucose-
containing glycoconjugates were used to detect L-fucose in tissue sections. Multifocally, 
there were small amounts of lectin staining at the apical cytoplasmic membrane of the 
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endometrial glands and endometrium (Figure 5). There were occasional foci of staining 
within luminal contents of endometrial glands (Figure 5).   
There was abundant cytoplasmic staining in trophoblasts for NFκB in the positive 
control (field case), in the uninfected tissue (negative control) and in the IV inoculated 
sheep. Staining for TLR 4 was not detected in uninfected tissue or in the experimentally 
inoculated sheep but there was abundant multifocal staining in infected chorioallantoic 
villi from the field abortion case, (Figures 6 and 7).  
There were small amounts of apoptotic nuclei randomly distributed throughout 
sections of placenta in no significantly quantifiable amount in the field case of C. jejuni 
abortion, the negative control and the experimentally inoculated ewe. There was a 
complete lack of caspase 3 signal detection from placental sections from inoculated sheep 
and from the negative control.  In the field case, multifocally, there was abundant 
cytoplasmic staining for caspase 3 within stromal cells and trophoblasts of the 
chorioallantoic villi (Figure 8). 
Discussion 
In culture, mucins promote the growth of C. jejuni and in infected guinea pigs the 
organism localizes to regions of the placenta containing both neutral and acid mucin.
8
 
Special stains and immunohistochemistry were used in order to determine potential 
factors that may contribute to this fetoplacental trophism in sheep. In this study the 
organism consistently localized to regions in the infected ovine placenta and uterus with 
strong staining for both neutral and acid mucin, that is, C. jejuni was found in the fetal 
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villi of the ovine placentome and within endometrial glands where there were significant 
amounts of mucin.  
L-fucose is reported to be both growth promoting and chemoattractive for C. 
jejuni.
8
  Lectin histochemistry demonstrated that there was L-fucose present at the apical 
cytoplasmic membrane of the endometrial glands and endometrium and occasional foci 
within lumen contents of endometrial glands. This correlates well with the 
immunohistochemical detection of the organism within ovine endometrial glands in this 
study. Virulent strains of C. jejuni, of which IA3902 is an isolate, possess a genomic 
island (cj0480c-cj0490) that is upregulated in the presence of mucin and L-fucose, where 
fucose metabolism is independent of ATP or GTP activation 
27
 and this may help to 
explain the localization of the organism within the uterus.  
In murine studies,
19
 it was also found that C. jejuni is trophic for mucin and L-
fucose. Overall, these findings suggest that after bacteremia, localization of the organism 
may be initially to the endometrium and endometrial glands, then to the fetoplacental 
unit. This is in agreement with histological findings in which there were large numbers of 
neutrophils within endometrial glands (endometritis) and few to no neutrophils within the 
body of the placentome 48 hours post intravenous inoculation of C. jejuni IA3902 
(submitted for publication). Interestingly, endometritis was also reported in guinea pigs 
48 hours post-challenge with IA3902 
7
 and was a feature of C. jejuni induced abortion in 
sheep after IV inoculation.
14
 
Previously, it was shown that some strains of C. jejuni readily obtained iron from 
external sources like hemin and hemoglobin by a common pathway and possibly from 
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compounds other than heme.
22
 It was also thought that iron was necessary for 
Campylobacter infection as there was decreased growth of the organism in iron deficient 
environments.
9
  In the current study, there was low iron staining multifocally within the 
ovine placentome, chorioallantoic membranes and in the endometrial glands where C. 
jejuni was also localized by IHC. This is in agreement with findings from the guinea pig 
abortion model, where there was a low to moderate amount of iron intracellularly and 
extracellularly in the guinea pig placenta.
8
  While C. jejuni IA3902 was found to be 
trophic for iron in the murine placenta which had moderate iron deposits within the 
parenchyma of the placental disc, the organism was also located at the periphery of the 
placental discs where iron deposits were low or absent (submitted for publication). 
Interestingly, it was demonstrated that there was down-regulation of iron uptake systems 
in IA3902.
31
 Therefore it is possible that the hypervirulent strain may have adapted to 
multiply even in the apparent low iron environment of the ovine placenta.  
The lack of significant signal for apoptosis and complete lack of signal in the 
caspase 3 IHC may suggest that placental apoptosis was not a significant feature of 
abortion 2 days post inoculation. In the field abortion case, multifocally, there was 
abundant cytoplasmic staining for caspase 3 within stromal cells and trophoblasts of the 
chorioallantoic villi. This is in agreement with another study that reported the 
upregulation of apoptosis genes with C. jejuni abortion in sheep.
24
  Of note is that the 
sheep in that study aborted 2 weeks post oral inoculation and the effect of the delay in 
onset of abortion on apoptotic processes is unknown. C. jejuni was reported to cause 
rapid oncotic rather than apoptotic death in enterocytes which was not prevented by 
caspase inhibition and which also suggests oncosis via a caspase independent 
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mechanism.
18
  This feature of C. jejuni is distinctly different from other enteric bacterial 
pathogens like Salmonella spp. that induce cell death via activation of caspases
5
 yet is in 
agreement with findings of C. jejuni caspase independent macrophage cell death.
26
 
Additionally, C. jejuni has also been reported to activate cellular inflammasomes upon 
cellular invasion without cytotoxicity or cell death.
4
   
In different murine infection models TLR4 dependent signaling of C. jejuni 
lipopolysaccharide has been determined to be a key factor in immunopathology 
associated with the organism.
15
  C. jejuni endotoxin bound to its carrier protein engages 
the TLR4 along with the cytoplasmic membrane receptor CD14 and an accessory protein 
MD4. Once this occurs, through the activation of the transcription factor, NFκB and a 
signaling complex with downstream signaling through mitogen-activated protein (MAP) 
kinase and phosphatidylinositol-3 (PI3) kinase pathways, there is ultimately the 
transcription of proinflammatory cytokine genes and cellular release of cytokines like IL1 
and TNF.
23
  
Three sheep from this study aborted between 12 and 48 hours post IV inoculation 
and this was hypothesized to be due to the effects of endotoxin because of the short time 
interval between inoculation and abortion and the presence of clinical signs in the ewes 
consistent with endotoxemia. Yet there was no signal detected in response to TLR4 
antibody in the placentome from these sheep or the uninfected control, but there was 
abundant positive signal from the field case. This may suggest that while TLR4 
endotoxin activation may not play a significant role in rapidly-induced experimental 
sheep abortions, such as occurred in our study, it likely plays a role in nature as there was 
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abundant staining for both C. jejuni and TLR4 in the chorioallantoic membranes of the 
field abortion case. 
There was no discernible difference in NFκB signal from field case, uninfected 
control or inoculated sheep. One possible explanation for these results is that placental 
activation of TLR4 and production of NFκB was not the cause of the abortions seen in 
these experimentally infected sheep. It been also been reported that C. jejuni could 
activate NFκB independently of either TLR2 or TLR4.2  From previous work from our 
lab, it was found that murine placental cytokine production played a role in the 
reproductive pathology of C. jejuni (submitted for publication). It is therefore also 
possible that different pathways are involved in C jejuni endotoxin mediated abortion in 
sheep that are not primarily dependent on placental activation of NFκB production. 
Another possibility was that these abortions were more likely influenced by endotoxin 
mediated prostaglandin production, though Sanad et al reported down-regulation of the 
gene encoding prostaglandin E receptor 4 in a sheep that aborted compared to control 
sheep.
24
  
Very little is known about the pathogenic mechanisms of C. jejuni mediated 
abortion or the spatial localization of the organism and its trophic factors within infected 
ovine placenta. We confirmed the presence of the organism in uterus and fetoplacental 
tissue via high microbial recovery and IHC for the MOMP. Within the ovine placenta, C. 
jejuni IA3902 is trophic for L-fucose as indicated by multifocal areas of lectin staining at 
the apical cytoplasmic membrane of the endometrial glands and endometrium and 
occasional foci of staining within lumen content of endometrial glands. Another trophic 
factor within the sheep placenta was mucin, both neutral mucin and acid mucin, primarily 
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located within endometrial glands and fetal villi of the placentome, two locations with 
intense immunohistochemical staining for the organism. C. jejuni IA3902 was present 
within endometrial glands where low iron deposits were also rarely identified. NFκB did 
not appear to play a discernable role in ovine abortion caused by C. jejuni IA3902 in our 
studies.  
Two days post inoculation significant amounts of apoptosis were not detectable in 
the ovine placenta after infection with C. jejuni IA3902 using a commercial assay and 
this was supported by absence of caspase 3 activation, a central executioner involved in 
both the intrinsic and extrinsic apoptotic pathways. In the C. jejuni confirmed field 
abortion case, multifocally there was abundant cytoplasmic staining of stromal cells and 
trophoblasts of the chorioallantoic villi for caspase 3 and multifocal, abundant staining of 
TLR4 within trophoblasts of the chorioallantoic membranes. Therefore the roles of 
caspase 3 and TLR4 in the pathogenesis of ovine Campylobacter abortion warrant further 
investigation. 
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Table 1. Final optimized conditions for incubation times and Antigen Retrieval 
specifications for Immunohistochemistry and Histochemistry procedures 
Primary Antibody Incubation Antigen Retrieval Buffer Heat induction 
MOMP 1 hr Protease  (0.1% Tris pH7.4) 20 min at RT 
Lectin 30 min Tris at pH 9 20 min steam 
NFκB 2 hr Citrate buffer at pH 6 20 min steam 
Caspase 3 1 hr Citrate buffer at pH 6 5 min microwave 
TLR4 1 hr Citrate buffer at pH 6 20 min steam 
 
 
 
Table 2. Lectin histochemistry and special stains of ovine reproductive tissue 
a
 
 Subjective Quantification of Staining* 
Tissue Type Neutral mucin Acid mucin Iron
b
 LTA
c
 
Placentome +++ +++ + - 
Chorioallantoic 
membranes 
++ +++ + - 
Endometrium  ++ +++ - + 
Endometrial glands +++ +++ + + 
a Values reported represent the average of all evaluated placental material 
* - = negative; + = low; ++ = moderate; +++ = abundant 
LTA, Lotus tetragonolobus lectin agglutinin  
b Multifocal staining 
c Apical membrane staining 
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Figures 1-8. Photomicrographs of ovine placenta and endometrial glands after 
infection with C. jejuni IA3902. (1 and 2) Placentome after IHC for the membrane outer 
protein of C. jejuni (MOMP), 1 – foci of positive stain within endometrial gland content 
and 2 – foci of positive stain within fetal villi. (3) Abundant PAS stain for neutral mucin 
within endometrial gland content. (4) Alcian blue stain for acid mucin with abundant 
staining of fetal villi. (5) Lectin histochemistry for LTA, with moderate to abundant 
multifocal, apical membrane staining of endometrial cells of the yolk sac and 
extracellular staining of endometrial gland content. (6) TLR4 IHC with abundant 
multifocal TLR4 staining within trophoblasts of the chorioallantoic fetal membranes (7) 
Higher magnification of TLR4 staining within trophoblasts x40 mag. (8) Caspase 3 IHC 
with cytoplasmic staining of stromal cells and trophoblasts of the chorioallantoic villi. 
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CHAPTER 6: GENERAL CONCLUSIONS 
 
Conclusions and Recommendations for Future Research 
A tetracycline resistant C. jejuni clone, C. jejuni clone SA has replaced C. fetus as 
the predominant Campylobacter species causing sheep abortion in the United States.
1
  
Specific amino acid substitutions in loop 4 of the MOMP encoded by porA are 
responsible for the hypervirulence of this clone.
3
  The pathogenesis of placental infection 
caused by this agent and the mechanism of abortion induction are unknown. A primary 
objective of the previously described studies (chapters 2-5) was to attempt to elucidate 
important aspects of the pathogenesis of C. jejuni clone SA on the pregnant uterus. 
Towards this end, several components of this research attempted to characterize aspects 
of the cellular and molecular pathology of C. jejuni clone SA in the fetoplacental unit and 
to improve animal models used to study the pathogenesis of this disease.  
 
Pregnant mice can be used as a model to study the reproductive pathology of  
C. jejuni IA3902 using the endpoint of positive microbial culture of the organism 
from the fetoplacental unit.  
In chapter 2, the pregnant murine model of C. jejuni IA3902 infection was 
investigated and it was demonstrated that the organism is trophic for neutral mucin, iron 
and L-fucose within the murine placental. These findings as well as the histological 
changes are similar to what has been demonstrated for infected guinea pig placentas.      
C jejuni IA3902 has affinity for the murine reproductive tract, specifically the 
fetoplacental unit, where it is capable of producing a necrotizing placentitis with positive 
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microbial recovery after both IP and oral challenge in BALB/c and CD-1 pregnant mice.  
Gross reproductive pathology following inoculation included necrosuppurative 
placentitis, fetal resorption, intrauterine fetal death, stillborn pups and multifocal 
hepatitis. With further modifications of the murine model, it is likely that abortion, a 
feature of the ideal laboratory model would be induced. Experimental design changes to 
improve the model might include higher oral doses, challenge earlier in pregnancy and 
the use of genetically modified mice. 
 
Pro-inflammatory and anti-inflammatory cytokines were produced from the C. 
jejuni infected murine placenta and these could be measured in the maternal serum 
and semi quantitated within the uterus and placenta of Campylobacter jejuni IA3902 
infected mice by the use of in situ hybridization. 
Interleukin 1 beta (IL1β), interleukin 10 (IL 10), interleukin 17A (IL17A), tumor 
necrosis factor alpha (TNF α) and interferon gamma (IFN γ) are expressed by specific 
cells from C. jejuni clone SA infected fetoplacental tissue. There was a statistically 
significant increase for each of these cytokines post infection with C. jejuni IA3902. The 
findings of chapter 3 demonstrate that: (1) Cytokines play a role in modulating the 
placental infection and reproductive pathology of C. jejuni IA3902 infected pregnant 
BALB/c and CD-1 mice (2) Cytokines can be measured in the maternal serum and that 
levels are increased after fetoplacental and uterine infection with the organism and (3) 
Trophoblasts within the placental disc are the main source of these cytokines. Interleukin 
6 (IL6) did not appear to have a significant role in the uterine or placental pathology with 
C. jejuni IA3902 in either BALB/c or CD1 mice.   
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The cytokine studies identified cells producing specific pro-inflammatory and 
anti-inflammatory cytokines after the murine placenta is infected with C. jejuni IA3902. 
This work demonstrated that cytokines could be semi quantitated using in situ 
hybridization and quantitated via maternal cytokine serum testing. Further work is needed 
to determine the exact role of each of these cytokines in modulating the course of 
infection with C. jejuni and in the pathogenesis of fetal death and abortion caused by the 
pathogen. The use of cytokine agonists and antagonists in the therapeutic management of 
a wide variety of inflammatory conditions suggests consideration for the possible use of 
these agents to study the potential roles of these cytokines in the pathogenesis of 
abortion, with the eventual goal of evaluating the potential for pharmacologic 
management of infectious abortion. 
 
Fetoplacental infection in sheep was established following IV inoculation, 
though abortion within 48 hours does not mimic what is observed with naturally 
occurring disease. 
In Chapter 4, we report on our attempts to establish a sheep model for C. jejuni 
clone SA abortion and investigated the effects on pregnant sheep after oral, 
intraperitoneal and intravenous inoculation of the pathogen. Large doses of C. jejuni 
IA3902 administered orally and IP failed to result in demonstrable fetoplacental 
infection.  Three sheep that were inoculated intravenously (IV) aborted and three died. In 
one of these sheep, C. jejuni was recovered in high numbers from the placenta and uterus 
and in moderate numbers from the fetal lung and liver. In the placentome of this animal, 
there were degenerative histological changes with rounded, swollen trophoblasts, cellular 
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and nuclear debris we well as vascular congestion and hemorrhage. 
Immunohistochemistry (IHC) confirmed the presence of the organism within 
trophoblasts, fetal villi and endometrial glands. This is the first report of the organism 
within fetal villi and endometrial glands of infected ovine reproductive tissues.  
Further analyses conducted on confirmed infected sheep placenta were reported in 
Chapter 5. Our ovine studies found that C. jejuni was localized to areas in the ovine 
placentome where there were significant amounts of neutral and acid mucin, including 
the fetal villi and endometrial glands and where L-fucose was present, also within the 
endometrial glands. C. jejuni IA3902 was found within endometrial glands where low 
iron deposits were also rarely identified. Significant amounts of apoptosis were not 
detectable and this was supported by absence of caspase 3 signal identification. In the C. 
jejuni confirmed field abortion case multifocally there was abundant cytoplasmic staining 
of stromal cells and trophoblasts of the chorioallantoic villi for caspase 3 and multifocal, 
abundant staining of TLR4 within chorioallantoic membranes. Therefore the roles of 
caspase 3 and TLR4 in the pathogenesis of ovine Campylobacter abortion therefore 
warrant further investigation. 
 
Sheep placenta infected with C. jejuni IA3902 demonstrate increased caspase 
3 activity by stromal cells and trophoblasts of the chorioallantoic membrane 
compared with normal uninfected pregnant chorioallantoic ovine membranes.  
While this feature was not observed in experimentally inoculated sheep, this 
finding suggests that apoptosis is part of the mechanism of placental injury induced by C. 
jejuni clone SA and requires further examination. Caspase 1 and caspase 11 are involved 
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in NLRP3 inflammasome activation after Gram-negative bacteria LPS bind to TLR4
2
 and 
the activation of these caspases in the pathophysiologic mechanisms of C. jejuni clone 
SA abortion should be analyzed.   
 
C. jejuni IA3902 infected sheep placenta had increased expression of TLR4 
from trophoblasts of the chorioallantoic membranes.  
This is the first report of TLR4 up-regulation and warrants further investigation 
using larger numbers of infected sheep placenta. NFκB, a main downstream mediator that 
is activated upon binding of TLR4 did not demonstrate increased expression compared to 
uninfected placenta using light microscopy. These studies should be repeated using other 
techniques and testing for other downstream targets. 
 
 
References 
1  Sahin O, Plummer PJ, Jordan DM, Sulaj K, Pereira S, Robbe-Austerman S, et al.: 
Emergence of a Tetracycline-Resistant Campylobacter jejuni Clone Associated 
with Outbreaks of Ovine Abortion in the United States. Journal of Clinical 
Microbiology 2008:46(5):1663-1671. 
 
2  Sharma D, Kanneganti T-D: The cell biology of inflammasomes: Mechanisms of 
inflammasome activation and regulation. The Journal of Cell Biology 
2016:213(6):617-629. 
 
3  Wu Z, Periaswamy B, Sahin O, Yaeger M, Plummer P, Zhai W, et al.: Point mutations 
in the major outer membrane protein drive hypervirulence of a rapidly expanding 
clone of Campylobacter jejuni. Proceedings of the National Academy of Sciences 
2016:113(38):10690-10695. 
 
 
 
135 
 
ACKNOWLEDGEMENTS 
 
I would like to sincerely thank Dr. Michael Yaeger, my major professor, for his 
patience and guidance during my graduate studies at Iowa State University. I would like 
to extend thanks to my program of committee: Drs. Qijing Zhang, Paul Plummer, Jesse 
Hostetter and Mark Ackermann. Thanks to Dr. Orhan Sahin for help that he was always 
willing to provide. 
I express my gratitude to the faculty, staff, residents and graduate students of the 
Veterinary Pathology Department of the College of Veterinary Medicine for the amazing 
learning opportunities and professional courtesies extended to me, especially to the 
departmental chair, Dr. Joseph Haynes.  
To my parents, family and friends, heartfelt thanks for all the support.  
To my children, Ivana and Yadav, for your endless love and encouragement, I am 
forever grateful to you both. 
 
 
 
 
 
 
 
 
